This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-590-3p | AADAT | 0.86 | 0.00013 | -0.43 | 0.07498 | miRanda | -0.19 | 0.00309 | NA | |
2 | hsa-miR-590-3p | AAK1 | 0.86 | 0.00013 | -0.1 | 0.28347 | PITA | -0.16 | 0 | NA | |
3 | hsa-miR-590-3p | AASS | 0.86 | 0.00013 | -0.79 | 0.00013 | miRanda | -0.5 | 0 | NA | |
4 | hsa-miR-590-3p | ABAT | 0.86 | 0.00013 | -1.27 | 0 | PITA; miRanda | -0.18 | 0.01008 | NA | |
5 | hsa-miR-590-3p | ABCA1 | 0.86 | 0.00013 | 0.61 | 0.0002 | miRanda | -0.24 | 0 | NA | |
6 | hsa-miR-361-5p | ABCA10 | 0.54 | 0 | -0.57 | 0.03674 | miRanda | -0.48 | 0.00391 | NA | |
7 | hsa-miR-590-3p | ABCA10 | 0.86 | 0.00013 | -0.57 | 0.03674 | miRanda | -0.6 | 0 | NA | |
8 | hsa-miR-590-3p | ABCA4 | 0.86 | 0.00013 | -1.16 | 1.0E-5 | miRanda | -0.2 | 0.00484 | NA | |
9 | hsa-miR-590-3p | ABCA5 | 0.86 | 0.00013 | -0.62 | 0.00028 | miRanda | -0.13 | 0.00548 | NA | |
10 | hsa-miR-590-3p | ABCA6 | 0.86 | 0.00013 | -1.09 | 0.0003 | miRanda | -0.67 | 0 | NA | |
11 | hsa-miR-361-5p | ABCA8 | 0.54 | 0 | -2.99 | 0 | miRanda | -1.5 | 0 | NA | |
12 | hsa-miR-590-3p | ABCA8 | 0.86 | 0.00013 | -2.99 | 0 | miRanda | -0.96 | 0 | NA | |
13 | hsa-miR-590-3p | ABCA9 | 0.86 | 0.00013 | -1.38 | 0.00017 | miRanda | -0.91 | 0 | NA | |
14 | hsa-miR-590-3p | ABCB1 | 0.86 | 0.00013 | -0.7 | 0.00397 | miRanda | -0.25 | 0.00011 | NA | |
15 | hsa-miR-590-3p | ABCB4 | 0.86 | 0.00013 | 0.15 | 0.50554 | miRanda | -0.21 | 0.00059 | NA | |
16 | hsa-miR-361-5p | ABCB5 | 0.54 | 0 | -0.96 | 0.04077 | miRanda | -0.68 | 0.01555 | NA | |
17 | hsa-miR-590-3p | ABCB5 | 0.86 | 0.00013 | -0.96 | 0.04077 | miRanda | -0.94 | 0 | NA | |
18 | hsa-miR-590-3p | ABCC9 | 0.86 | 0.00013 | -0.47 | 0.14121 | miRanda | -0.92 | 0 | NA | |
19 | hsa-miR-361-5p | ABCD2 | 0.54 | 0 | -1.04 | 0.0005 | miRanda | -1.07 | 0 | NA | |
20 | hsa-miR-590-3p | ABCD2 | 0.86 | 0.00013 | -1.04 | 0.0005 | miRanda | -0.29 | 0.00029 | NA | |
21 | hsa-miR-590-3p | ABCG2 | 0.86 | 0.00013 | -1.55 | 0 | miRanda | -0.34 | 0.00011 | NA | |
22 | hsa-miR-590-3p | ABHD12B | 0.86 | 0.00013 | 0.27 | 0.58173 | miRanda | -0.42 | 0.0012 | NA | |
23 | hsa-miR-125a-5p | ABHD2 | -0.26 | 0.11611 | 0.47 | 0.00888 | miRanda | -0.19 | 0.00441 | NA | |
24 | hsa-miR-590-3p | ABI2 | 0.86 | 0.00013 | 0.18 | 0.14787 | miRanda | -0.24 | 0 | NA | |
25 | hsa-miR-590-3p | ABI3BP | 0.86 | 0.00013 | -2.06 | 0 | miRanda | -0.93 | 0 | NA | |
26 | hsa-miR-361-5p | ABL1 | 0.54 | 0 | -0.21 | 0.07804 | miRanda | -0.2 | 0.0072 | NA | |
27 | hsa-miR-590-3p | ABL2 | 0.86 | 0.00013 | 0.82 | 0 | PITA | -0.12 | 0.00011 | NA | |
28 | hsa-miR-361-5p | ACACB | 0.54 | 0 | -1.41 | 0 | miRanda | -0.48 | 0.00065 | NA | |
29 | hsa-miR-361-5p | ACAD8 | 0.54 | 0 | -0.33 | 0.0001 | miRanda | -0.12 | 0.02142 | NA | |
30 | hsa-miR-590-3p | ACADL | 0.86 | 0.00013 | -3.43 | 0 | miRanda | -0.6 | 0 | NA | |
31 | hsa-miR-590-3p | ACADM | 0.86 | 0.00013 | -1.05 | 0 | miRanda | -0.13 | 0.00096 | NA | |
32 | hsa-miR-361-5p | ACADSB | 0.54 | 0 | -0.98 | 0 | miRanda | -0.25 | 0.00853 | NA | |
33 | hsa-miR-590-3p | ACADSB | 0.86 | 0.00013 | -0.98 | 0 | miRanda | -0.14 | 0.00102 | NA | |
34 | hsa-miR-590-3p | ACOT2 | 0.86 | 0.00013 | -0.72 | 0 | miRanda | -0.11 | 0.00115 | NA | |
35 | hsa-miR-590-3p | ACOX2 | 0.86 | 0.00013 | -1.86 | 0 | miRanda | -0.57 | 0 | NA | |
36 | hsa-miR-125a-5p | ACPP | -0.26 | 0.11611 | -0.16 | 0.64505 | miRanda | -0.43 | 0.00059 | NA | |
37 | hsa-miR-590-3p | ACSL1 | 0.86 | 0.00013 | -0.58 | 4.0E-5 | miRanda | -0.19 | 0 | NA | |
38 | hsa-miR-361-5p | ACSL6 | 0.54 | 0 | -1.59 | 0 | miRanda | -0.53 | 0.00792 | NA | |
39 | hsa-miR-590-3p | ACSL6 | 0.86 | 0.00013 | -1.59 | 0 | miRanda | -0.29 | 0.0014 | NA | |
40 | hsa-miR-590-3p | ACSM5 | 0.86 | 0.00013 | -1.28 | 5.0E-5 | miRanda | -0.39 | 1.0E-5 | NA | |
41 | hsa-miR-590-3p | ACSS3 | 0.86 | 0.00013 | -0.4 | 0.15502 | miRanda | -0.41 | 0 | NA | |
42 | hsa-miR-590-3p | ACTB | 0.86 | 0.00013 | -0.25 | 0.01736 | miRanda | -0.14 | 0 | NA | |
43 | hsa-miR-361-5p | ACTC1 | 0.54 | 0 | -1.57 | 0.00051 | miRanda | -1.26 | 0 | NA | |
44 | hsa-miR-590-3p | ACTC1 | 0.86 | 0.00013 | -1.57 | 0.00051 | miRanda | -0.88 | 0 | NA | |
45 | hsa-miR-361-5p | ACTG1 | 0.54 | 0 | 0 | 0.98112 | miRNAWalker2 validate; PITA; miRanda | -0.14 | 0.03668 | NA | |
46 | hsa-miR-590-3p | ACTG2 | 0.86 | 0.00013 | -2.75 | 0 | miRanda | -1.51 | 0 | NA | |
47 | hsa-miR-590-3p | ACTN1 | 0.86 | 0.00013 | 0.14 | 0.44606 | miRanda | -0.48 | 0 | NA | |
48 | hsa-miR-15a-5p | ACTR1A | 1.08 | 0 | -0.4 | 0 | miRNAWalker2 validate | -0.15 | 0 | NA | |
49 | hsa-miR-590-3p | ACVR1 | 0.86 | 0.00013 | 0.28 | 0.00234 | miRanda | -0.11 | 1.0E-5 | NA | |
50 | hsa-miR-590-3p | ACVR2A | 0.86 | 0.00013 | -0.41 | 0.00039 | PITA; miRanda | -0.18 | 0 | NA | |
51 | hsa-miR-590-3p | ADAL | 0.86 | 0.00013 | -0.34 | 0.01893 | miRanda | -0.12 | 0.00194 | NA | |
52 | hsa-miR-125a-5p | ADAM10 | -0.26 | 0.11611 | 0.68 | 0 | miRanda | -0.23 | 0 | NA | |
53 | hsa-miR-361-5p | ADAM19 | 0.54 | 0 | 0.19 | 0.3039 | miRanda | -0.29 | 0.00766 | NA | |
54 | hsa-miR-590-3p | ADAM19 | 0.86 | 0.00013 | 0.19 | 0.3039 | miRanda | -0.19 | 7.0E-5 | NA | |
55 | hsa-miR-590-3p | ADAM22 | 0.86 | 0.00013 | 0.64 | 0.00696 | PITA; miRanda | -0.31 | 0 | NA | |
56 | hsa-miR-590-3p | ADAM23 | 0.86 | 0.00013 | -0.71 | 0.00863 | miRanda | -0.53 | 0 | NA | |
57 | hsa-miR-590-3p | ADAM32 | 0.86 | 0.00013 | 0.73 | 0.00299 | miRanda | -0.39 | 0 | NA | |
58 | hsa-miR-590-3p | ADAM33 | 0.86 | 0.00013 | -1.82 | 1.0E-5 | miRanda | -1.1 | 0 | NA | |
59 | hsa-miR-590-3p | ADAMTS1 | 0.86 | 0.00013 | -1.46 | 0 | miRanda | -0.57 | 0 | NA | |
60 | hsa-miR-590-3p | ADAMTS16 | 0.86 | 0.00013 | 0.41 | 0.25777 | miRanda | -0.4 | 5.0E-5 | NA | |
61 | hsa-miR-590-3p | ADAMTS17 | 0.86 | 0.00013 | -0.45 | 0.11385 | miRanda | -0.26 | 0.00067 | NA | |
62 | hsa-miR-590-3p | ADAMTS19 | 0.86 | 0.00013 | -1.3 | 0.01069 | PITA; miRanda | -0.62 | 1.0E-5 | NA | |
63 | hsa-miR-590-3p | ADAMTS3 | 0.86 | 0.00013 | 0.38 | 0.04723 | miRanda | -0.31 | 0 | NA | |
64 | hsa-miR-590-3p | ADAMTS5 | 0.86 | 0.00013 | 0.19 | 0.27716 | PITA; miRanda | -0.29 | 0 | NA | |
65 | hsa-miR-590-3p | ADAMTS6 | 0.86 | 0.00013 | 1.2 | 0 | miRanda | -0.24 | 4.0E-5 | NA | |
66 | hsa-miR-590-3p | ADAMTS8 | 0.86 | 0.00013 | -1.48 | 0.00069 | miRanda | -0.98 | 0 | NA | |
67 | hsa-miR-590-3p | ADAMTS9 | 0.86 | 0.00013 | 0.8 | 3.0E-5 | miRanda | -0.22 | 3.0E-5 | NA | |
68 | hsa-miR-590-3p | ADAMTSL1 | 0.86 | 0.00013 | -1.98 | 0 | miRanda | -0.48 | 0 | NA | |
69 | hsa-miR-590-3p | ADAMTSL3 | 0.86 | 0.00013 | -1.56 | 0 | miRanda | -0.81 | 0 | NA | |
70 | hsa-miR-590-3p | ADARB1 | 0.86 | 0.00013 | -0.34 | 0.06631 | miRanda | -0.44 | 0 | NA | |
71 | hsa-miR-590-3p | ADARB2 | 0.86 | 0.00013 | -2.03 | 0 | miRanda | -0.51 | 0 | NA | |
72 | hsa-miR-361-5p | ADCY2 | 0.54 | 0 | -1.53 | 4.0E-5 | PITA; miRanda | -1.04 | 0 | NA | |
73 | hsa-miR-361-5p | ADCY9 | 0.54 | 0 | -0.36 | 0.01911 | miRanda | -0.32 | 0.00051 | NA | |
74 | hsa-miR-590-3p | ADCY9 | 0.86 | 0.00013 | -0.36 | 0.01911 | miRanda | -0.34 | 0 | NA | |
75 | hsa-miR-361-5p | ADCYAP1 | 0.54 | 0 | -1.7 | 0.00038 | miRanda | -1.41 | 0 | NA | |
76 | hsa-miR-590-3p | ADCYAP1 | 0.86 | 0.00013 | -1.7 | 0.00038 | PITA; miRanda | -0.85 | 0 | NA | |
77 | hsa-miR-590-3p | ADD1 | 0.86 | 0.00013 | -0.51 | 0 | PITA; miRanda | -0.19 | 0 | NA | |
78 | hsa-miR-590-3p | ADH1A | 0.86 | 0.00013 | -2.38 | 0 | miRanda | -0.67 | 0 | NA | |
79 | hsa-miR-590-3p | ADH1B | 0.86 | 0.00013 | -3.72 | 0 | miRanda | -1.09 | 0 | NA | |
80 | hsa-miR-590-3p | ADH4 | 0.86 | 0.00013 | -2.17 | 0.00155 | miRanda | -0.45 | 0.01695 | NA | |
81 | hsa-miR-590-3p | ADH5 | 0.86 | 0.00013 | -0.37 | 0.00013 | miRanda | -0.16 | 0 | NA | |
82 | hsa-miR-361-5p | ADHFE1 | 0.54 | 0 | -2.92 | 0 | miRanda | -1.34 | 0 | NA | |
83 | hsa-miR-590-3p | ADIPOQ | 0.86 | 0.00013 | -4.48 | 0 | PITA; miRanda | -1.08 | 0 | NA | |
84 | hsa-miR-361-5p | ADRA2A | 0.54 | 0 | 0.02 | 0.95612 | miRanda | -0.61 | 0.01464 | NA | |
85 | hsa-miR-590-3p | ADRB2 | 0.86 | 0.00013 | -2.78 | 0 | PITA; miRanda | -0.49 | 0 | NA | |
86 | hsa-miR-125a-5p | AEN | -0.26 | 0.11611 | 0.71 | 0 | miRanda | -0.15 | 0.00216 | NA | |
87 | hsa-miR-590-3p | AFAP1 | 0.86 | 0.00013 | 0.34 | 0.01222 | PITA; miRanda | -0.3 | 0 | NA | |
88 | hsa-miR-590-3p | AFAP1L2 | 0.86 | 0.00013 | -0.28 | 0.15434 | miRanda | -0.3 | 0 | NA | |
89 | hsa-miR-590-3p | AFF1 | 0.86 | 0.00013 | -0.38 | 0.00053 | PITA; miRanda | -0.2 | 0 | NA | |
90 | hsa-miR-590-3p | AFF3 | 0.86 | 0.00013 | -2.37 | 0 | PITA; miRanda | -0.79 | 0 | NA | |
91 | hsa-miR-361-5p | AFF4 | 0.54 | 0 | -0.27 | 0.01565 | miRanda | -0.18 | 0.00599 | NA | |
92 | hsa-miR-590-3p | AFF4 | 0.86 | 0.00013 | -0.27 | 0.01565 | PITA; miRanda | -0.21 | 0 | NA | |
93 | hsa-miR-590-3p | AGAP1 | 0.86 | 0.00013 | -0.05 | 0.72151 | miRanda | -0.16 | 0 | NA | |
94 | hsa-miR-361-5p | AGBL5 | 0.54 | 0 | -0.73 | 0 | miRanda | -0.18 | 0.02806 | NA | |
95 | hsa-miR-125a-5p | AGGF1 | -0.26 | 0.11611 | 0.11 | 0.14733 | miRanda | -0.15 | 0 | NA | |
96 | hsa-miR-590-3p | AGL | 0.86 | 0.00013 | -0.17 | 0.16618 | PITA; miRanda | -0.16 | 0 | NA | |
97 | hsa-miR-590-3p | AGTR1 | 0.86 | 0.00013 | -2.47 | 0 | miRanda | -1.34 | 0 | NA | |
98 | hsa-miR-361-5p | AGTR2 | 0.54 | 0 | -1.87 | 0.00044 | PITA; miRanda | -0.96 | 0.00317 | NA | |
99 | hsa-miR-590-3p | AGTR2 | 0.86 | 0.00013 | -1.87 | 0.00044 | PITA; miRanda | -1.09 | 0 | NA | |
100 | hsa-miR-590-3p | AHCYL1 | 0.86 | 0.00013 | -0.48 | 0 | miRanda | -0.1 | 0 | NA | |
101 | hsa-miR-361-5p | AHCYL2 | 0.54 | 0 | -0.32 | 0.14924 | miRanda | -0.5 | 0.00021 | NA | |
102 | hsa-miR-125a-5p | AHI1 | -0.26 | 0.11611 | 0.25 | 0.03721 | miRanda | -0.13 | 0.00423 | NA | |
103 | hsa-miR-590-3p | AHI1 | 0.86 | 0.00013 | 0.25 | 0.03721 | miRanda | -0.16 | 0 | NA | |
104 | hsa-miR-361-5p | AHNAK | 0.54 | 0 | -1.21 | 0 | miRanda | -0.71 | 0 | NA | |
105 | hsa-miR-590-3p | AHNAK | 0.86 | 0.00013 | -1.21 | 0 | miRanda | -0.49 | 0 | NA | |
106 | hsa-miR-590-3p | AHSA2 | 0.86 | 0.00013 | 0.53 | 0.00119 | miRanda | -0.11 | 0.01532 | NA | |
107 | hsa-miR-125a-5p | AIFM1 | -0.26 | 0.11611 | -0.04 | 0.71464 | miRanda | -0.12 | 0.00457 | NA | |
108 | hsa-miR-590-3p | AK3 | 0.86 | 0.00013 | -0.7 | 0 | miRanda | -0.1 | 0.00087 | NA | |
109 | hsa-miR-361-5p | AK5 | 0.54 | 0 | -1.47 | 0 | miRanda | -0.62 | 0.00075 | NA | |
110 | hsa-miR-590-3p | AK5 | 0.86 | 0.00013 | -1.47 | 0 | miRanda | -0.63 | 0 | NA | |
111 | hsa-miR-125a-5p | AKAP11 | -0.26 | 0.11611 | 0.2 | 0.09825 | miRanda | -0.15 | 0.0008 | NA | |
112 | hsa-miR-590-3p | AKAP11 | 0.86 | 0.00013 | 0.2 | 0.09825 | miRanda | -0.21 | 0 | NA | |
113 | hsa-miR-361-5p | AKAP12 | 0.54 | 0 | -0.93 | 0.0028 | miRanda | -0.68 | 0.00031 | NA | |
114 | hsa-miR-590-3p | AKAP12 | 0.86 | 0.00013 | -0.93 | 0.0028 | miRanda | -0.82 | 0 | NA | |
115 | hsa-miR-361-5p | AKAP6 | 0.54 | 0 | -1.59 | 3.0E-5 | miRanda | -0.88 | 0.00012 | NA | |
116 | hsa-miR-590-3p | AKAP6 | 0.86 | 0.00013 | -1.59 | 3.0E-5 | PITA; miRanda | -1.15 | 0 | NA | |
117 | hsa-miR-590-3p | AKAP7 | 0.86 | 0.00013 | -0.63 | 0.00332 | miRanda | -0.15 | 0.01252 | NA | |
118 | hsa-miR-361-5p | AKNAD1 | 0.54 | 0 | -0.46 | 0.00016 | miRanda | -0.27 | 0.00021 | NA | |
119 | hsa-miR-590-3p | AKNAD1 | 0.86 | 0.00013 | -0.46 | 0.00016 | miRanda | -0.2 | 0 | NA | |
120 | hsa-miR-361-5p | AKR1B10 | 0.54 | 0 | -3.97 | 0 | miRanda | -2 | 1.0E-5 | NA | |
121 | hsa-miR-590-3p | AKR1E2 | 0.86 | 0.00013 | 0.15 | 0.6468 | miRanda | -0.21 | 0.01521 | NA | |
122 | hsa-miR-361-5p | AKR7A2 | 0.54 | 0 | -0.7 | 0 | miRanda | -0.26 | 0.00055 | NA | |
123 | hsa-miR-15a-5p | AKT3 | 1.08 | 0 | -0.27 | 0.18865 | miRNAWalker2 validate; miRTarBase | -0.6 | 0 | NA | |
124 | hsa-miR-590-3p | AKTIP | 0.86 | 0.00013 | -0.38 | 0.00082 | miRanda | -0.21 | 0 | NA | |
125 | hsa-miR-590-3p | ALAD | 0.86 | 0.00013 | -0.72 | 0 | miRanda | -0.11 | 3.0E-5 | NA | |
126 | hsa-miR-590-3p | ALDH1A3 | 0.86 | 0.00013 | 0.12 | 0.61313 | miRanda | -0.4 | 0 | NA | |
127 | hsa-miR-590-3p | ALDH1L1 | 0.86 | 0.00013 | -2.34 | 0 | miRanda | -0.66 | 0 | NA | |
128 | hsa-miR-590-3p | ALDH1L2 | 0.86 | 0.00013 | 0.23 | 0.32096 | miRanda | -0.28 | 1.0E-5 | NA | |
129 | hsa-miR-361-5p | ALDH6A1 | 0.54 | 0 | -1.2 | 0 | miRanda | -0.34 | 9.0E-5 | NA | |
130 | hsa-miR-590-3p | ALDH6A1 | 0.86 | 0.00013 | -1.2 | 0 | miRanda | -0.18 | 0 | NA | |
131 | hsa-miR-125a-5p | ALPK1 | -0.26 | 0.11611 | 0.31 | 0.03014 | miRanda | -0.14 | 0.00622 | NA | |
132 | hsa-miR-590-3p | ALPK3 | 0.86 | 0.00013 | -0.07 | 0.79023 | miRanda | -0.58 | 0 | NA | |
133 | hsa-miR-590-3p | ALS2CR11 | 0.86 | 0.00013 | 0.94 | 0.00621 | miRanda | -0.4 | 1.0E-5 | NA | |
134 | hsa-miR-361-5p | AMFR | 0.54 | 0 | -0.4 | 1.0E-5 | miRanda | -0.19 | 0.00074 | NA | |
135 | hsa-miR-590-3p | AMIGO1 | 0.86 | 0.00013 | -0.83 | 0.00159 | miRanda | -0.48 | 0 | NA | |
136 | hsa-miR-590-3p | AMN1 | 0.86 | 0.00013 | -0.3 | 0.02124 | miRanda | -0.11 | 0.00183 | NA | |
137 | hsa-miR-590-3p | AMOTL2 | 0.86 | 0.00013 | 0.15 | 0.30776 | miRanda | -0.13 | 0.00055 | NA | |
138 | hsa-miR-590-3p | AMT | 0.86 | 0.00013 | -1.49 | 0 | miRanda | -0.19 | 0.00371 | NA | |
139 | hsa-miR-590-3p | AMY2B | 0.86 | 0.00013 | 0.17 | 0.24319 | miRanda | -0.17 | 4.0E-5 | NA | |
140 | hsa-miR-15a-5p | ANAPC16 | 1.08 | 0 | -0.56 | 0 | miRNAWalker2 validate | -0.14 | 0.00018 | NA | |
141 | hsa-miR-590-3p | ANAPC16 | 0.86 | 0.00013 | -0.56 | 0 | miRanda | -0.14 | 0 | NA | |
142 | hsa-miR-590-3p | ANGPT1 | 0.86 | 0.00013 | -1.12 | 0 | PITA; miRanda | -0.54 | 0 | NA | |
143 | hsa-miR-125a-5p | ANGPT2 | -0.26 | 0.11611 | 1.53 | 0 | miRanda | -0.17 | 0.02642 | NA | |
144 | hsa-miR-590-3p | ANGPTL1 | 0.86 | 0.00013 | -2.71 | 0 | PITA; miRanda | -1.33 | 0 | NA | |
145 | hsa-miR-361-5p | ANGPTL2 | 0.54 | 0 | -0.02 | 0.91748 | miRanda | -0.49 | 0.00032 | NA | |
146 | hsa-miR-590-3p | ANK2 | 0.86 | 0.00013 | -1.6 | 1.0E-5 | PITA; miRanda | -0.96 | 0 | NA | |
147 | hsa-miR-590-3p | ANK3 | 0.86 | 0.00013 | -0.55 | 0.00086 | PITA; miRanda | -0.2 | 1.0E-5 | NA | |
148 | hsa-miR-590-3p | ANKAR | 0.86 | 0.00013 | -0.16 | 0.29664 | miRanda | -0.26 | 0 | NA | |
149 | hsa-miR-590-3p | ANKDD1A | 0.86 | 0.00013 | -0.34 | 0.0368 | PITA; miRanda | -0.37 | 0 | NA | |
150 | hsa-miR-361-5p | ANKFY1 | 0.54 | 0 | -0.04 | 0.63304 | miRanda | -0.11 | 0.04447 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEUROGENESIS | 379 | 1402 | 1.942e-35 | 9.038e-32 |
2 | CELL DEVELOPMENT | 361 | 1426 | 1.222e-27 | 2.844e-24 |
3 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 407 | 1672 | 1.908e-27 | 2.96e-24 |
4 | CELLULAR COMPONENT MORPHOGENESIS | 253 | 900 | 2.881e-26 | 3.352e-23 |
5 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 227 | 788 | 3.588e-25 | 2.782e-22 |
6 | CIRCULATORY SYSTEM DEVELOPMENT | 227 | 788 | 3.588e-25 | 2.782e-22 |
7 | CELL PROJECTION ORGANIZATION | 245 | 902 | 3.533e-23 | 2.055e-20 |
8 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 239 | 872 | 3.378e-23 | 2.055e-20 |
9 | NEURON DIFFERENTIATION | 238 | 874 | 1.08e-22 | 5.583e-20 |
10 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 211 | 750 | 4.703e-22 | 2.188e-19 |
11 | HEAD DEVELOPMENT | 202 | 709 | 7.454e-22 | 3.153e-19 |
12 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 160 | 513 | 9.457e-22 | 3.667e-19 |
13 | REGULATION OF CELL DIFFERENTIATION | 353 | 1492 | 1.775e-21 | 6.355e-19 |
14 | CELL PART MORPHOGENESIS | 185 | 633 | 2.015e-21 | 6.697e-19 |
15 | NEURON PROJECTION DEVELOPMENT | 163 | 545 | 4.362e-20 | 1.353e-17 |
16 | RESPONSE TO ENDOGENOUS STIMULUS | 339 | 1450 | 9.46e-20 | 2.751e-17 |
17 | NEURON DEVELOPMENT | 191 | 687 | 1.971e-19 | 5.396e-17 |
18 | NEURON PROJECTION MORPHOGENESIS | 130 | 402 | 2.327e-19 | 5.761e-17 |
19 | TISSUE DEVELOPMENT | 350 | 1518 | 2.352e-19 | 5.761e-17 |
20 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 280 | 1142 | 2.48e-19 | 5.769e-17 |
21 | VASCULATURE DEVELOPMENT | 144 | 469 | 5.304e-19 | 1.175e-16 |
22 | REGULATION OF CELL DEVELOPMENT | 219 | 836 | 9.379e-19 | 1.984e-16 |
23 | REGULATION OF NEURON DIFFERENTIATION | 161 | 554 | 1.61e-18 | 3.258e-16 |
24 | BIOLOGICAL ADHESION | 256 | 1032 | 2.037e-18 | 3.948e-16 |
25 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 248 | 1008 | 2.154e-17 | 4.008e-15 |
26 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 118 | 368 | 2.254e-17 | 4.033e-15 |
27 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 238 | 957 | 2.571e-17 | 4.43e-15 |
28 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 126 | 408 | 5.301e-17 | 8.81e-15 |
29 | BLOOD VESSEL MORPHOGENESIS | 116 | 364 | 7.071e-17 | 1.135e-14 |
30 | HEART DEVELOPMENT | 137 | 466 | 2.178e-16 | 3.311e-14 |
31 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 247 | 1021 | 2.206e-16 | 3.311e-14 |
32 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 130 | 437 | 4.654e-16 | 6.767e-14 |
33 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 314 | 1395 | 7.454e-16 | 1.051e-13 |
34 | REGULATION OF TRANSPORT | 386 | 1804 | 1.135e-15 | 1.554e-13 |
35 | REGULATION OF CELL PROJECTION ORGANIZATION | 153 | 558 | 3.209e-15 | 4.267e-13 |
36 | SYNAPSE ORGANIZATION | 60 | 145 | 5.88e-15 | 7.6e-13 |
37 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 288 | 1275 | 8.55e-15 | 1.075e-12 |
38 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 378 | 1784 | 1.103e-14 | 1.35e-12 |
39 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 379 | 1791 | 1.231e-14 | 1.469e-12 |
40 | REGULATION OF MEMBRANE POTENTIAL | 105 | 343 | 4.114e-14 | 4.669e-12 |
41 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 80 | 232 | 4.073e-14 | 4.669e-12 |
42 | POSITIVE REGULATION OF CELL DEVELOPMENT | 132 | 472 | 5.331e-14 | 5.906e-12 |
43 | SINGLE ORGANISM BEHAVIOR | 113 | 384 | 8.903e-14 | 9.634e-12 |
44 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 96 | 306 | 9.809e-14 | 1.037e-11 |
45 | RESPONSE TO NITROGEN COMPOUND | 207 | 859 | 1.054e-13 | 1.089e-11 |
46 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 261 | 1152 | 1.225e-13 | 1.213e-11 |
47 | BEHAVIOR | 140 | 516 | 1.204e-13 | 1.213e-11 |
48 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 174 | 689 | 1.46e-13 | 1.415e-11 |
49 | TISSUE MORPHOGENESIS | 143 | 533 | 1.697e-13 | 1.611e-11 |
50 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 350 | 1656 | 1.797e-13 | 1.673e-11 |
51 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 189 | 771 | 2.488e-13 | 2.27e-11 |
52 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 94 | 303 | 3.717e-13 | 3.326e-11 |
53 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 198 | 823 | 4.394e-13 | 3.857e-11 |
54 | RESPONSE TO HORMONE | 210 | 893 | 8.911e-13 | 7.678e-11 |
55 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 340 | 1618 | 9.259e-13 | 7.833e-11 |
56 | ANGIOGENESIS | 90 | 293 | 2.188e-12 | 1.818e-10 |
57 | POSITIVE REGULATION OF CELL COMMUNICATION | 323 | 1532 | 2.427e-12 | 1.981e-10 |
58 | CELLULAR RESPONSE TO HORMONE STIMULUS | 143 | 552 | 3.048e-12 | 2.446e-10 |
59 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 319 | 1518 | 5.135e-12 | 3.982e-10 |
60 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 133 | 505 | 5.092e-12 | 3.982e-10 |
61 | EMBRYO DEVELOPMENT | 207 | 894 | 6.142e-12 | 4.685e-10 |
62 | ORGAN MORPHOGENESIS | 197 | 841 | 6.834e-12 | 5.085e-10 |
63 | REGULATION OF SYSTEM PROCESS | 133 | 507 | 6.885e-12 | 5.085e-10 |
64 | LOCOMOTION | 246 | 1114 | 1.116e-11 | 8.112e-10 |
65 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 188 | 799 | 1.405e-11 | 1.006e-09 |
66 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 292 | 1381 | 2.228e-11 | 1.571e-09 |
67 | FOREBRAIN DEVELOPMENT | 101 | 357 | 2.398e-11 | 1.666e-09 |
68 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 288 | 1360 | 2.599e-11 | 1.778e-09 |
69 | RESPONSE TO WOUNDING | 142 | 563 | 2.962e-11 | 1.998e-09 |
70 | NEGATIVE REGULATION OF CELL COMMUNICATION | 258 | 1192 | 3.081e-11 | 2.048e-09 |
71 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 187 | 801 | 3.243e-11 | 2.125e-09 |
72 | REGULATION OF PROTEIN MODIFICATION PROCESS | 347 | 1710 | 5.448e-11 | 3.473e-09 |
73 | REGULATION OF CELL MORPHOGENESIS | 139 | 552 | 5.429e-11 | 3.473e-09 |
74 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 95 | 337 | 1.159e-10 | 7.287e-09 |
75 | REGULATION OF HYDROLASE ACTIVITY | 279 | 1327 | 1.222e-10 | 7.582e-09 |
76 | POSITIVE REGULATION OF GENE EXPRESSION | 349 | 1733 | 1.25e-10 | 7.656e-09 |
77 | INTRACELLULAR SIGNAL TRANSDUCTION | 321 | 1572 | 1.513e-10 | 9.142e-09 |
78 | REGULATION OF ION TRANSPORT | 145 | 592 | 1.736e-10 | 1.036e-08 |
79 | SYNAPSE ASSEMBLY | 32 | 69 | 3.694e-10 | 2.175e-08 |
80 | REGULATION OF GTPASE ACTIVITY | 159 | 673 | 4.039e-10 | 2.349e-08 |
81 | EYE DEVELOPMENT | 91 | 326 | 4.964e-10 | 2.851e-08 |
82 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 176 | 767 | 5.285e-10 | 2.999e-08 |
83 | CIRCULATORY SYSTEM PROCESS | 99 | 366 | 5.742e-10 | 3.219e-08 |
84 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 215 | 983 | 5.886e-10 | 3.26e-08 |
85 | TELENCEPHALON DEVELOPMENT | 70 | 228 | 6.115e-10 | 3.347e-08 |
86 | RESPONSE TO ABIOTIC STIMULUS | 222 | 1024 | 6.957e-10 | 3.764e-08 |
87 | SYNAPTIC SIGNALING | 110 | 424 | 9.131e-10 | 4.883e-08 |
88 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 200 | 905 | 9.9e-10 | 5.197e-08 |
89 | MODULATION OF SYNAPTIC TRANSMISSION | 85 | 301 | 9.941e-10 | 5.197e-08 |
90 | MESENCHYME DEVELOPMENT | 61 | 190 | 1.102e-09 | 5.695e-08 |
91 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 124 | 498 | 1.261e-09 | 6.45e-08 |
92 | SENSORY ORGAN DEVELOPMENT | 123 | 493 | 1.291e-09 | 6.53e-08 |
93 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 222 | 1036 | 2.03e-09 | 1.005e-07 |
94 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 222 | 1036 | 2.03e-09 | 1.005e-07 |
95 | EMBRYONIC MORPHOGENESIS | 131 | 539 | 2.243e-09 | 1.099e-07 |
96 | MUSCLE STRUCTURE DEVELOPMENT | 110 | 432 | 2.861e-09 | 1.372e-07 |
97 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 31 | 70 | 2.833e-09 | 1.372e-07 |
98 | CELL CELL SIGNALING | 173 | 767 | 2.911e-09 | 1.382e-07 |
99 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 353 | 1805 | 3.478e-09 | 1.635e-07 |
100 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 69 | 232 | 3.585e-09 | 1.668e-07 |
101 | MESENCHYMAL CELL DIFFERENTIATION | 47 | 134 | 3.703e-09 | 1.706e-07 |
102 | POSITIVE REGULATION OF TRANSPORT | 203 | 936 | 3.753e-09 | 1.712e-07 |
103 | REGULATION OF KINASE ACTIVITY | 174 | 776 | 4.148e-09 | 1.874e-07 |
104 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 373 | 1929 | 4.65e-09 | 2.08e-07 |
105 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 75 | 262 | 4.944e-09 | 2.191e-07 |
106 | EPITHELIUM DEVELOPMENT | 204 | 945 | 5.092e-09 | 2.225e-07 |
107 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 199 | 917 | 5.117e-09 | 2.225e-07 |
108 | TUBE DEVELOPMENT | 132 | 552 | 5.743e-09 | 2.474e-07 |
109 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 132 | 554 | 7.279e-09 | 3.107e-07 |
110 | NEURAL CREST CELL MIGRATION | 25 | 51 | 7.43e-09 | 3.143e-07 |
111 | AMEBOIDAL TYPE CELL MIGRATION | 51 | 154 | 7.739e-09 | 3.244e-07 |
112 | REGULATION OF DEVELOPMENTAL GROWTH | 80 | 289 | 8.243e-09 | 3.424e-07 |
113 | MORPHOGENESIS OF AN EPITHELIUM | 102 | 400 | 9.872e-09 | 4.065e-07 |
114 | NEURON PROJECTION GUIDANCE | 62 | 205 | 1.086e-08 | 4.432e-07 |
115 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 67 | 229 | 1.243e-08 | 5.028e-07 |
116 | NEGATIVE CHEMOTAXIS | 21 | 39 | 1.383e-08 | 5.546e-07 |
117 | CELL MOTILITY | 182 | 835 | 1.692e-08 | 6.673e-07 |
118 | LOCALIZATION OF CELL | 182 | 835 | 1.692e-08 | 6.673e-07 |
119 | CELLULAR RESPONSE TO PEPTIDE | 76 | 274 | 1.757e-08 | 6.871e-07 |
120 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 296 | 1492 | 1.794e-08 | 6.955e-07 |
121 | UROGENITAL SYSTEM DEVELOPMENT | 81 | 299 | 1.919e-08 | 7.379e-07 |
122 | REGULATION OF GROWTH | 145 | 633 | 2.035e-08 | 7.761e-07 |
123 | PROTEIN PHOSPHORYLATION | 201 | 944 | 2.051e-08 | 7.761e-07 |
124 | COGNITION | 71 | 251 | 2.151e-08 | 8.072e-07 |
125 | REGULATION OF BLOOD CIRCULATION | 80 | 295 | 2.229e-08 | 8.296e-07 |
126 | REGULATION OF METAL ION TRANSPORT | 86 | 325 | 2.314e-08 | 8.546e-07 |
127 | REGULATION OF CELL PROLIFERATION | 296 | 1496 | 2.351e-08 | 8.613e-07 |
128 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 211 | 1004 | 2.683e-08 | 9.753e-07 |
129 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 76 | 278 | 3.437e-08 | 1.24e-06 |
130 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 354 | 1848 | 3.505e-08 | 1.254e-06 |
131 | CEREBRAL CORTEX DEVELOPMENT | 38 | 105 | 4.318e-08 | 1.534e-06 |
132 | CAMERA TYPE EYE MORPHOGENESIS | 37 | 101 | 4.478e-08 | 1.578e-06 |
133 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 52 | 166 | 4.534e-08 | 1.586e-06 |
134 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 139 | 609 | 5.037e-08 | 1.749e-06 |
135 | NEURON MIGRATION | 39 | 110 | 5.495e-08 | 1.894e-06 |
136 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 57 | 191 | 6.987e-08 | 2.391e-06 |
137 | REGULATION OF CELLULAR LOCALIZATION | 256 | 1277 | 7.124e-08 | 2.42e-06 |
138 | HINDBRAIN DEVELOPMENT | 45 | 137 | 7.577e-08 | 2.555e-06 |
139 | REGULATION OF CELL SUBSTRATE ADHESION | 53 | 173 | 7.702e-08 | 2.568e-06 |
140 | TUBE MORPHOGENESIS | 84 | 323 | 7.726e-08 | 2.568e-06 |
141 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 162 | 740 | 7.785e-08 | 2.569e-06 |
142 | NEURAL CREST CELL DIFFERENTIATION | 30 | 75 | 8.599e-08 | 2.818e-06 |
143 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 45 | 138 | 9.651e-08 | 3.14e-06 |
144 | POSITIVE REGULATION OF MAPK CASCADE | 112 | 470 | 9.889e-08 | 3.195e-06 |
145 | REGULATION OF MAPK CASCADE | 147 | 660 | 1.045e-07 | 3.353e-06 |
146 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 151 | 684 | 1.256e-07 | 4.002e-06 |
147 | CELL CELL ADHESION | 137 | 608 | 1.398e-07 | 4.396e-06 |
148 | PALLIUM DEVELOPMENT | 48 | 153 | 1.397e-07 | 4.396e-06 |
149 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 81 | 312 | 1.417e-07 | 4.414e-06 |
150 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 230 | 1135 | 1.423e-07 | 4.414e-06 |
151 | STEM CELL DIFFERENTIATION | 56 | 190 | 1.443e-07 | 4.446e-06 |
152 | NEGATIVE REGULATION OF TRANSPORT | 109 | 458 | 1.568e-07 | 4.8e-06 |
153 | EYE MORPHOGENESIS | 44 | 136 | 1.72e-07 | 5.23e-06 |
154 | SENSORY ORGAN MORPHOGENESIS | 66 | 239 | 1.783e-07 | 5.386e-06 |
155 | MULTICELLULAR ORGANISMAL SIGNALING | 41 | 123 | 1.799e-07 | 5.401e-06 |
156 | REGULATION OF CYTOSKELETON ORGANIZATION | 117 | 502 | 1.817e-07 | 5.421e-06 |
157 | REGULATION OF AXONOGENESIS | 51 | 168 | 1.852e-07 | 5.489e-06 |
158 | SKELETAL SYSTEM DEVELOPMENT | 108 | 455 | 2.055e-07 | 6.053e-06 |
159 | CELLULAR RESPONSE TO INSULIN STIMULUS | 46 | 146 | 2.195e-07 | 6.423e-06 |
160 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 184 | 876 | 2.231e-07 | 6.489e-06 |
161 | REGULATION OF HEART CONTRACTION | 62 | 221 | 2.266e-07 | 6.549e-06 |
162 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 111 | 472 | 2.311e-07 | 6.637e-06 |
163 | RESPONSE TO PEPTIDE | 98 | 404 | 2.557e-07 | 7.211e-06 |
164 | RESPONSE TO OXYGEN LEVELS | 80 | 311 | 2.552e-07 | 7.211e-06 |
165 | HEART MORPHOGENESIS | 60 | 212 | 2.532e-07 | 7.211e-06 |
166 | CYTOSKELETON ORGANIZATION | 177 | 838 | 2.589e-07 | 7.257e-06 |
167 | MUSCLE CELL DIFFERENTIATION | 65 | 237 | 2.89e-07 | 8.051e-06 |
168 | NEGATIVE REGULATION OF CELL PROLIFERATION | 142 | 643 | 2.914e-07 | 8.071e-06 |
169 | ENSHEATHMENT OF NEURONS | 33 | 91 | 3.099e-07 | 8.482e-06 |
170 | AXON ENSHEATHMENT | 33 | 91 | 3.099e-07 | 8.482e-06 |
171 | EMBRYONIC ORGAN DEVELOPMENT | 98 | 406 | 3.269e-07 | 8.895e-06 |
172 | NEGATIVE REGULATION OF PHOSPHORYLATION | 101 | 422 | 3.338e-07 | 9.03e-06 |
173 | WOUND HEALING | 110 | 470 | 3.375e-07 | 9.078e-06 |
174 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 78 | 303 | 3.471e-07 | 9.283e-06 |
175 | NEGATIVE REGULATION OF LOCOMOTION | 70 | 263 | 3.578e-07 | 9.515e-06 |
176 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 123 | 541 | 3.674e-07 | 9.658e-06 |
177 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 123 | 541 | 3.674e-07 | 9.658e-06 |
178 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 45 | 144 | 3.841e-07 | 9.987e-06 |
179 | PROTEIN LOCALIZATION | 340 | 1805 | 3.842e-07 | 9.987e-06 |
180 | POSITIVE REGULATION OF KINASE ACTIVITY | 112 | 482 | 3.887e-07 | 1.005e-05 |
181 | EMBRYONIC ORGAN MORPHOGENESIS | 73 | 279 | 4.165e-07 | 1.071e-05 |
182 | DENDRITE MORPHOGENESIS | 20 | 42 | 4.302e-07 | 1.1e-05 |
183 | MUSCLE TISSUE DEVELOPMENT | 72 | 275 | 4.853e-07 | 1.234e-05 |
184 | LONG TERM SYNAPTIC POTENTIATION | 19 | 39 | 5.346e-07 | 1.345e-05 |
185 | REGULATION OF TRANSMEMBRANE TRANSPORT | 101 | 426 | 5.349e-07 | 1.345e-05 |
186 | REGULATION OF TRANSFERASE ACTIVITY | 194 | 946 | 6.042e-07 | 1.511e-05 |
187 | RESPONSE TO STEROID HORMONE | 114 | 497 | 6.129e-07 | 1.525e-05 |
188 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 108 | 465 | 6.388e-07 | 1.581e-05 |
189 | PLASMA MEMBRANE ORGANIZATION | 57 | 203 | 6.632e-07 | 1.633e-05 |
190 | REGULATION OF CATABOLIC PROCESS | 156 | 731 | 7.043e-07 | 1.725e-05 |
191 | RHYTHMIC PROCESS | 76 | 298 | 7.23e-07 | 1.761e-05 |
192 | REGULATION OF DENDRITE DEVELOPMENT | 39 | 120 | 7.41e-07 | 1.796e-05 |
193 | REGULATION OF INTRACELLULAR TRANSPORT | 136 | 621 | 8.433e-07 | 2.033e-05 |
194 | DIGESTIVE SYSTEM DEVELOPMENT | 45 | 148 | 9.058e-07 | 2.169e-05 |
195 | RESPONSE TO LIPID | 183 | 888 | 9.09e-07 | 2.169e-05 |
196 | POSITIVE REGULATION OF LOCOMOTION | 99 | 420 | 9.151e-07 | 2.172e-05 |
197 | CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 15 | 27 | 9.808e-07 | 2.317e-05 |
198 | IN UTERO EMBRYONIC DEVELOPMENT | 78 | 311 | 1.055e-06 | 2.48e-05 |
199 | REGULATION OF SYNAPSE ORGANIZATION | 37 | 113 | 1.151e-06 | 2.69e-05 |
200 | REGULATION OF SYNAPTIC PLASTICITY | 43 | 140 | 1.161e-06 | 2.702e-05 |
201 | DENDRITE DEVELOPMENT | 29 | 79 | 1.185e-06 | 2.722e-05 |
202 | LEARNING | 41 | 131 | 1.187e-06 | 2.722e-05 |
203 | RETINA DEVELOPMENT IN CAMERA TYPE EYE | 41 | 131 | 1.187e-06 | 2.722e-05 |
204 | DEVELOPMENTAL GROWTH | 82 | 333 | 1.252e-06 | 2.857e-05 |
205 | REGULATION OF CELL GROWTH | 93 | 391 | 1.283e-06 | 2.912e-05 |
206 | MUSCLE SYSTEM PROCESS | 72 | 282 | 1.34e-06 | 3.026e-05 |
207 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 36 | 110 | 1.618e-06 | 3.637e-05 |
208 | SMOOTHENED SIGNALING PATHWAY | 27 | 72 | 1.696e-06 | 3.793e-05 |
209 | REGULATION OF CELL JUNCTION ASSEMBLY | 26 | 68 | 1.711e-06 | 3.81e-05 |
210 | FAT CELL DIFFERENTIATION | 35 | 106 | 1.782e-06 | 3.948e-05 |
211 | REGULATION OF CELL DEATH | 280 | 1472 | 2.002e-06 | 4.415e-05 |
212 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 72 | 285 | 2.033e-06 | 4.441e-05 |
213 | PALATE DEVELOPMENT | 30 | 85 | 2.028e-06 | 4.441e-05 |
214 | CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 13 | 22 | 2.049e-06 | 4.455e-05 |
215 | RESPONSE TO INSULIN | 56 | 205 | 2.135e-06 | 4.62e-05 |
216 | CELLULAR RESPONSE TO OXYGEN LEVELS | 43 | 143 | 2.171e-06 | 4.654e-05 |
217 | RESPONSE TO MECHANICAL STIMULUS | 57 | 210 | 2.166e-06 | 4.654e-05 |
218 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 47 | 162 | 2.285e-06 | 4.877e-05 |
219 | ACTION POTENTIAL | 32 | 94 | 2.315e-06 | 4.919e-05 |
220 | RESPONSE TO INORGANIC SUBSTANCE | 108 | 479 | 2.805e-06 | 5.933e-05 |
221 | REGULATION OF CELL ADHESION | 135 | 629 | 2.873e-06 | 6.049e-05 |
222 | REGULATION OF HOMEOSTATIC PROCESS | 102 | 447 | 3.01e-06 | 6.309e-05 |
223 | REGULATION OF OSSIFICATION | 50 | 178 | 3.095e-06 | 6.457e-05 |
224 | MEMBRANE ORGANIZATION | 182 | 899 | 3.169e-06 | 6.583e-05 |
225 | OVULATION CYCLE | 36 | 113 | 3.285e-06 | 6.69e-05 |
226 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 100 | 437 | 3.292e-06 | 6.69e-05 |
227 | FOREBRAIN CELL MIGRATION | 24 | 62 | 3.293e-06 | 6.69e-05 |
228 | RESPONSE TO GROWTH FACTOR | 107 | 475 | 3.254e-06 | 6.69e-05 |
229 | EXTRACELLULAR STRUCTURE ORGANIZATION | 75 | 304 | 3.247e-06 | 6.69e-05 |
230 | REGULATION OF TRANSPORTER ACTIVITY | 54 | 198 | 3.392e-06 | 6.862e-05 |
231 | GLIAL CELL DIFFERENTIATION | 41 | 136 | 3.447e-06 | 6.944e-05 |
232 | METENCEPHALON DEVELOPMENT | 33 | 100 | 3.527e-06 | 7.075e-05 |
233 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 69 | 274 | 3.705e-06 | 7.399e-05 |
234 | ION TRANSPORT | 243 | 1262 | 3.99e-06 | 7.933e-05 |
235 | PLATELET ACTIVATION | 42 | 142 | 4.519e-06 | 8.947e-05 |
236 | REGULATION OF VESICLE MEDIATED TRANSPORT | 104 | 462 | 4.591e-06 | 9.051e-05 |
237 | REGULATION OF ORGANELLE ORGANIZATION | 228 | 1178 | 5.538e-06 | 0.0001087 |
238 | REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 30 | 5.634e-06 | 0.0001101 |
239 | DIGESTIVE TRACT MORPHOGENESIS | 20 | 48 | 5.734e-06 | 0.0001116 |
240 | GROWTH | 94 | 410 | 5.899e-06 | 0.0001144 |
241 | NERVE DEVELOPMENT | 25 | 68 | 6.149e-06 | 0.0001187 |
242 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 359 | 1977 | 6.671e-06 | 0.0001283 |
243 | EXCITATORY POSTSYNAPTIC POTENTIAL | 14 | 27 | 6.714e-06 | 0.0001286 |
244 | ACTIN FILAMENT BASED PROCESS | 101 | 450 | 7.159e-06 | 0.0001365 |
245 | ENDOTHELIUM DEVELOPMENT | 30 | 90 | 7.676e-06 | 0.0001452 |
246 | REGULATION OF CELL MATRIX ADHESION | 30 | 90 | 7.676e-06 | 0.0001452 |
247 | RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 19 | 45 | 7.755e-06 | 0.0001461 |
248 | REGULATION OF BLOOD PRESSURE | 47 | 169 | 8.084e-06 | 0.0001517 |
249 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 49 | 8.35e-06 | 0.000156 |
250 | GLIOGENESIS | 48 | 175 | 9.791e-06 | 0.0001815 |
251 | CELL PROLIFERATION | 140 | 672 | 9.77e-06 | 0.0001815 |
252 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 43 | 151 | 1.013e-05 | 0.0001871 |
253 | REGULATION OF DENDRITE MORPHOGENESIS | 26 | 74 | 1.049e-05 | 0.0001925 |
254 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 44 | 156 | 1.051e-05 | 0.0001925 |
255 | POSITIVE REGULATION OF CELL DEATH | 128 | 605 | 1.079e-05 | 0.0001969 |
256 | WNT SIGNALING PATHWAY | 82 | 351 | 1.09e-05 | 0.0001981 |
257 | POSITIVE REGULATION OF ION TRANSPORT | 60 | 236 | 1.131e-05 | 0.0002047 |
258 | NEURONAL ACTION POTENTIAL | 14 | 28 | 1.16e-05 | 0.0002093 |
259 | REGULATION OF POTASSIUM ION TRANSPORT | 28 | 83 | 1.181e-05 | 0.0002123 |
260 | RESPONSE TO MONOAMINE | 16 | 35 | 1.19e-05 | 0.000213 |
261 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 20 | 50 | 1.2e-05 | 0.0002138 |
262 | NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 23 | 62 | 1.205e-05 | 0.000214 |
263 | MICROTUBULE BASED PROCESS | 113 | 522 | 1.216e-05 | 0.0002151 |
264 | NEGATIVE REGULATION OF GENE EXPRESSION | 278 | 1493 | 1.227e-05 | 0.0002155 |
265 | TRANSMISSION OF NERVE IMPULSE | 21 | 54 | 1.227e-05 | 0.0002155 |
266 | ARTERY DEVELOPMENT | 26 | 75 | 1.382e-05 | 0.0002411 |
267 | DOPAMINE METABOLIC PROCESS | 13 | 25 | 1.385e-05 | 0.0002411 |
268 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 54 | 207 | 1.389e-05 | 0.0002411 |
269 | CHEMICAL HOMEOSTASIS | 174 | 874 | 1.441e-05 | 0.0002493 |
270 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 43 | 153 | 1.45e-05 | 0.0002499 |
271 | NEGATIVE REGULATION OF CELL ADHESION | 57 | 223 | 1.562e-05 | 0.0002683 |
272 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 32 | 102 | 1.606e-05 | 0.0002747 |
273 | TAXIS | 102 | 464 | 1.633e-05 | 0.0002782 |
274 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 10 | 16 | 1.638e-05 | 0.0002782 |
275 | VASCULOGENESIS | 22 | 59 | 1.686e-05 | 0.0002853 |
276 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 103 | 470 | 1.705e-05 | 0.0002874 |
277 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 21 | 55 | 1.711e-05 | 0.0002874 |
278 | SINGLE ORGANISM CELL ADHESION | 101 | 459 | 1.718e-05 | 0.0002876 |
279 | ENDOMEMBRANE SYSTEM ORGANIZATION | 102 | 465 | 1.794e-05 | 0.0002992 |
280 | CELL SUBSTRATE ADHESION | 45 | 164 | 1.809e-05 | 0.0002996 |
281 | PHOSPHORYLATION | 233 | 1228 | 1.803e-05 | 0.0002996 |
282 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 36 | 121 | 1.828e-05 | 0.0003016 |
283 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 34 | 112 | 1.935e-05 | 0.0003182 |
284 | ENDOTHELIAL CELL DIFFERENTIATION | 25 | 72 | 1.948e-05 | 0.0003191 |
285 | MUSCLE ORGAN DEVELOPMENT | 67 | 277 | 2.103e-05 | 0.0003425 |
286 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 91 | 406 | 2.105e-05 | 0.0003425 |
287 | REGULATION OF BODY FLUID LEVELS | 109 | 506 | 2.148e-05 | 0.0003483 |
288 | NEGATIVE REGULATION OF CELL GROWTH | 46 | 170 | 2.166e-05 | 0.0003499 |
289 | POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 23 | 64 | 2.198e-05 | 0.0003539 |
290 | REGULATION OF GLUCOSE IMPORT | 22 | 60 | 2.294e-05 | 0.0003681 |
291 | REGENERATION | 44 | 161 | 2.482e-05 | 0.0003969 |
292 | CELLULAR MACROMOLECULE LOCALIZATION | 233 | 1234 | 2.521e-05 | 0.0004017 |
293 | RESPONSE TO CORTICOSTEROID | 47 | 176 | 2.562e-05 | 0.0004028 |
294 | HOMEOSTATIC PROCESS | 250 | 1337 | 2.556e-05 | 0.0004028 |
295 | REGULATION OF ION HOMEOSTASIS | 52 | 201 | 2.538e-05 | 0.0004028 |
296 | REGULATION OF ORGAN MORPHOGENESIS | 60 | 242 | 2.55e-05 | 0.0004028 |
297 | POSITIVE REGULATION OF AXONOGENESIS | 24 | 69 | 2.746e-05 | 0.0004303 |
298 | REGULATION OF CYTOPLASMIC TRANSPORT | 104 | 481 | 2.801e-05 | 0.0004374 |
299 | MUSCLE CELL DEVELOPMENT | 37 | 128 | 2.853e-05 | 0.0004439 |
300 | INNERVATION | 12 | 23 | 2.862e-05 | 0.0004439 |
301 | REGULATION OF EMBRYONIC DEVELOPMENT | 34 | 114 | 2.916e-05 | 0.0004508 |
302 | REGULATION OF PROTEIN LOCALIZATION | 185 | 950 | 2.993e-05 | 0.0004612 |
303 | REGULATION OF VASCULATURE DEVELOPMENT | 58 | 233 | 3.048e-05 | 0.000468 |
304 | AORTA DEVELOPMENT | 17 | 41 | 3.087e-05 | 0.0004725 |
305 | NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 14 | 30 | 3.142e-05 | 0.0004794 |
306 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 40 | 143 | 3.194e-05 | 0.0004857 |
307 | CYCLIC NUCLEOTIDE METABOLIC PROCESS | 21 | 57 | 3.22e-05 | 0.000488 |
308 | REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 9 | 14 | 3.235e-05 | 0.0004887 |
309 | SMOOTH MUSCLE CONTRACTION | 18 | 45 | 3.25e-05 | 0.0004893 |
310 | MELANOCYTE DIFFERENTIATION | 11 | 20 | 3.26e-05 | 0.0004893 |
311 | VESICLE MEDIATED TRANSPORT | 233 | 1239 | 3.316e-05 | 0.0004929 |
312 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 20 | 53 | 3.3e-05 | 0.0004929 |
313 | GLOMERULUS DEVELOPMENT | 19 | 49 | 3.315e-05 | 0.0004929 |
314 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 53 | 208 | 3.342e-05 | 0.0004953 |
315 | STRIATED MUSCLE CELL DIFFERENTIATION | 46 | 173 | 3.491e-05 | 0.0005156 |
316 | NEPHRON DEVELOPMENT | 34 | 115 | 3.56e-05 | 0.0005242 |
317 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 70 | 3.599e-05 | 0.0005283 |
318 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 34 | 3.753e-05 | 0.0005457 |
319 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 15 | 34 | 3.753e-05 | 0.0005457 |
320 | CAMP METABOLIC PROCESS | 15 | 34 | 3.753e-05 | 0.0005457 |
321 | REGULATION OF GLUCOSE METABOLIC PROCESS | 32 | 106 | 3.793e-05 | 0.0005498 |
322 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 52 | 204 | 3.903e-05 | 0.000564 |
323 | REGULATION OF ENDOCYTOSIS | 51 | 199 | 3.954e-05 | 0.0005686 |
324 | PATTERN SPECIFICATION PROCESS | 92 | 418 | 3.959e-05 | 0.0005686 |
325 | CELLULAR RESPONSE TO LIPID | 99 | 457 | 3.99e-05 | 0.0005689 |
326 | OVULATION CYCLE PROCESS | 28 | 88 | 3.998e-05 | 0.0005689 |
327 | REGULATION OF STEM CELL PROLIFERATION | 28 | 88 | 3.998e-05 | 0.0005689 |
328 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 278 | 1517 | 4.111e-05 | 0.0005822 |
329 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 127 | 616 | 4.117e-05 | 0.0005822 |
330 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 22 | 62 | 4.129e-05 | 0.0005823 |
331 | RESPONSE TO RADIATION | 91 | 413 | 4.165e-05 | 0.0005854 |
332 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 16 | 38 | 4.197e-05 | 0.0005882 |
333 | SECRETION | 122 | 588 | 4.326e-05 | 0.0006033 |
334 | FEMALE SEX DIFFERENTIATION | 34 | 116 | 4.33e-05 | 0.0006033 |
335 | REPRODUCTIVE SYSTEM DEVELOPMENT | 90 | 408 | 4.38e-05 | 0.0006083 |
336 | AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 17 | 42 | 4.476e-05 | 0.0006181 |
337 | POSITIVE REGULATION OF OSSIFICATION | 27 | 84 | 4.465e-05 | 0.0006181 |
338 | NEGATIVE REGULATION OF GROWTH | 58 | 236 | 4.512e-05 | 0.0006211 |
339 | MEMORY | 30 | 98 | 4.9e-05 | 0.0006725 |
340 | HEMOSTASIS | 72 | 311 | 4.977e-05 | 0.0006811 |
341 | CELL PROJECTION ASSEMBLY | 63 | 264 | 5.606e-05 | 0.0007649 |
342 | RESPONSE TO LIGHT STIMULUS | 66 | 280 | 5.652e-05 | 0.000769 |
343 | LIPID TRANSLOCATION | 11 | 21 | 5.933e-05 | 0.0008048 |
344 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 30 | 99 | 6.048e-05 | 0.0008158 |
345 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 30 | 99 | 6.048e-05 | 0.0008158 |
346 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 179 | 926 | 6.116e-05 | 0.000821 |
347 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 20 | 55 | 6.123e-05 | 0.000821 |
348 | RESPONSE TO ALCOHOL | 81 | 362 | 6.193e-05 | 0.000828 |
349 | PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 26 | 81 | 6.297e-05 | 0.0008359 |
350 | POSITIVE REGULATION OF CELL PROLIFERATION | 160 | 814 | 6.284e-05 | 0.0008359 |
351 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 12 | 6.305e-05 | 0.0008359 |
352 | REGULATION OF CELL SIZE | 45 | 172 | 6.445e-05 | 0.0008492 |
353 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 44 | 167 | 6.46e-05 | 0.0008492 |
354 | REGULATION OF FATTY ACID OXIDATION | 13 | 28 | 6.453e-05 | 0.0008492 |
355 | ORGAN GROWTH | 23 | 68 | 6.617e-05 | 0.0008673 |
356 | REGULATION OF COLLATERAL SPROUTING | 10 | 18 | 6.736e-05 | 0.0008804 |
357 | DEVELOPMENTAL CELL GROWTH | 25 | 77 | 7.01e-05 | 0.0009137 |
358 | SECRETION BY CELL | 103 | 486 | 7.053e-05 | 0.0009167 |
359 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 22 | 64 | 7.181e-05 | 0.0009308 |
360 | VASCULAR PROCESS IN CIRCULATORY SYSTEM | 43 | 163 | 7.535e-05 | 0.0009739 |
361 | REGULATION OF CALCIUM ION TRANSPORT | 52 | 209 | 7.742e-05 | 0.0009979 |
362 | INOSITOL LIPID MEDIATED SIGNALING | 35 | 124 | 7.921e-05 | 0.001018 |
363 | MEMBRANE ASSEMBLY | 12 | 25 | 8.252e-05 | 0.001049 |
364 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 20 | 56 | 8.213e-05 | 0.001049 |
365 | CONNECTIVE TISSUE DEVELOPMENT | 49 | 194 | 8.224e-05 | 0.001049 |
366 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 12 | 25 | 8.252e-05 | 0.001049 |
367 | NEGATIVE REGULATION OF CELL DEATH | 169 | 872 | 8.498e-05 | 0.001074 |
368 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 47 | 184 | 8.482e-05 | 0.001074 |
369 | RESPONSE TO METAL ION | 75 | 333 | 9.116e-05 | 0.001146 |
370 | REGULATION OF EXTENT OF CELL GROWTH | 30 | 101 | 9.101e-05 | 0.001146 |
371 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 65 | 279 | 9.26e-05 | 0.001161 |
372 | REGULATION OF HORMONE LEVELS | 101 | 478 | 9.309e-05 | 0.001164 |
373 | ADULT BEHAVIOR | 37 | 135 | 9.905e-05 | 0.001236 |
374 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 38 | 140 | 0.0001005 | 0.001251 |
375 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 21 | 61 | 0.0001015 | 0.001256 |
376 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 21 | 61 | 0.0001015 | 0.001256 |
377 | SECOND MESSENGER MEDIATED SIGNALING | 42 | 160 | 0.0001024 | 0.001264 |
378 | GLAND DEVELOPMENT | 86 | 395 | 0.0001035 | 0.001274 |
379 | REGULATION OF SYNAPSE ASSEMBLY | 25 | 79 | 0.000112 | 0.001375 |
380 | LOCOMOTORY BEHAVIOR | 46 | 181 | 0.0001141 | 0.001398 |
381 | RESPONSE TO OXIDATIVE STRESS | 78 | 352 | 0.0001172 | 0.001432 |
382 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 51 | 207 | 0.0001177 | 0.001433 |
383 | REGULATION OF EPITHELIAL CELL MIGRATION | 43 | 166 | 0.0001183 | 0.001437 |
384 | REGULATION OF MEMBRANE LIPID DISTRIBUTION | 15 | 37 | 0.0001222 | 0.001481 |
385 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 10 | 19 | 0.0001234 | 0.001481 |
386 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 26 | 84 | 0.0001242 | 0.001481 |
387 | TISSUE MIGRATION | 26 | 84 | 0.0001242 | 0.001481 |
388 | NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 10 | 19 | 0.0001234 | 0.001481 |
389 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 122 | 602 | 0.0001244 | 0.001481 |
390 | REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 10 | 19 | 0.0001234 | 0.001481 |
391 | RESPIRATORY SYSTEM DEVELOPMENT | 49 | 197 | 0.0001235 | 0.001481 |
392 | SPROUTING ANGIOGENESIS | 17 | 45 | 0.0001248 | 0.001481 |
393 | RESPONSE TO EXTERNAL STIMULUS | 323 | 1821 | 0.0001307 | 0.001547 |
394 | RESPONSE TO KETONE | 46 | 182 | 0.0001312 | 0.00155 |
395 | REGULATION OF CIRCADIAN RHYTHM | 30 | 103 | 0.0001347 | 0.001587 |
396 | REGULATED EXOCYTOSIS | 54 | 224 | 0.0001388 | 0.001631 |
397 | NEURON CELL CELL ADHESION | 9 | 16 | 0.0001395 | 0.001635 |
398 | REGULATION OF WNT SIGNALING PATHWAY | 70 | 310 | 0.0001414 | 0.001653 |
399 | REGULATION OF VASCULOGENESIS | 8 | 13 | 0.0001427 | 0.001664 |
400 | CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 58 | 246 | 0.0001531 | 0.001781 |
401 | CARDIAC SEPTUM DEVELOPMENT | 26 | 85 | 0.0001541 | 0.001788 |
402 | REGULATION OF NEURON MIGRATION | 13 | 30 | 0.0001546 | 0.001789 |
403 | LIPID PHOSPHORYLATION | 29 | 99 | 0.0001549 | 0.001789 |
404 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 30 | 104 | 0.000163 | 0.001877 |
405 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 18 | 50 | 0.0001637 | 0.001881 |
406 | REGULATION OF NEURON DEATH | 59 | 252 | 0.0001652 | 0.001893 |
407 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 17 | 46 | 0.0001709 | 0.001954 |
408 | CATECHOLAMINE METABOLIC PROCESS | 16 | 42 | 0.000175 | 0.001986 |
409 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 16 | 42 | 0.000175 | 0.001986 |
410 | CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 16 | 42 | 0.000175 | 0.001986 |
411 | POSITIVE REGULATION OF ENDOCYTOSIS | 32 | 114 | 0.0001757 | 0.001989 |
412 | REGULATION OF MUSCLE SYSTEM PROCESS | 48 | 195 | 0.0001878 | 0.002121 |
413 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 40 | 154 | 0.0001885 | 0.002124 |
414 | CARDIAC CHAMBER DEVELOPMENT | 38 | 144 | 0.00019 | 0.002128 |
415 | AGING | 61 | 264 | 0.0001902 | 0.002128 |
416 | REGULATION OF HEART RATE | 26 | 86 | 0.0001902 | 0.002128 |
417 | REGULATION OF NEUROTRANSMITTER LEVELS | 47 | 190 | 0.0001927 | 0.00215 |
418 | SINGLE ORGANISM CELLULAR LOCALIZATION | 171 | 898 | 0.0001956 | 0.002177 |
419 | ACTOMYOSIN STRUCTURE ORGANIZATION | 24 | 77 | 0.0001978 | 0.002191 |
420 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 24 | 77 | 0.0001978 | 0.002191 |
421 | CELL ACTIVATION | 115 | 568 | 0.0001997 | 0.002207 |
422 | CELL DEATH | 188 | 1001 | 0.0002045 | 0.002255 |
423 | CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 12 | 27 | 0.0002069 | 0.002271 |
424 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 12 | 27 | 0.0002069 | 0.002271 |
425 | MUSCLE CONTRACTION | 55 | 233 | 0.0002162 | 0.002368 |
426 | NEGATIVE REGULATION OF CHEMOTAXIS | 18 | 51 | 0.0002184 | 0.002385 |
427 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 123 | 616 | 0.0002219 | 0.002418 |
428 | MICROTUBULE CYTOSKELETON ORGANIZATION | 76 | 348 | 0.0002294 | 0.002494 |
429 | REGULATION OF SYNAPTIC VESICLE TRANSPORT | 13 | 31 | 0.0002304 | 0.002499 |
430 | REGULATION OF CELLULAR COMPONENT SIZE | 74 | 337 | 0.0002315 | 0.002505 |
431 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 52 | 218 | 0.0002412 | 0.002598 |
432 | CEREBRAL CORTEX CELL MIGRATION | 16 | 43 | 0.0002408 | 0.002598 |
433 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 32 | 116 | 0.0002489 | 0.002666 |
434 | REGULATION OF NEURON APOPTOTIC PROCESS | 47 | 192 | 0.0002498 | 0.002666 |
435 | MULTI MULTICELLULAR ORGANISM PROCESS | 51 | 213 | 0.0002497 | 0.002666 |
436 | CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 32 | 116 | 0.0002489 | 0.002666 |
437 | BONE DEVELOPMENT | 40 | 156 | 0.0002525 | 0.002683 |
438 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 40 | 156 | 0.0002525 | 0.002683 |
439 | REGULATION OF DOPAMINE METABOLIC PROCESS | 9 | 17 | 0.0002576 | 0.002718 |
440 | CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 9 | 17 | 0.0002576 | 0.002718 |
441 | REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 9 | 17 | 0.0002576 | 0.002718 |
442 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 19 | 56 | 0.0002657 | 0.002791 |
443 | OUTFLOW TRACT MORPHOGENESIS | 19 | 56 | 0.0002657 | 0.002791 |
444 | POST GOLGI VESICLE MEDIATED TRANSPORT | 25 | 83 | 0.0002671 | 0.002799 |
445 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 65 | 289 | 0.0002692 | 0.002815 |
446 | AXON REGENERATION | 11 | 24 | 0.0002735 | 0.002841 |
447 | IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 11 | 24 | 0.0002735 | 0.002841 |
448 | RENAL SYSTEM PROCESS | 29 | 102 | 0.0002728 | 0.002841 |
449 | REGULATION OF HORMONE SECRETION | 60 | 262 | 0.000275 | 0.002849 |
450 | POSITIVE REGULATION OF CATABOLIC PROCESS | 84 | 395 | 0.0002797 | 0.002892 |
451 | REGULATION OF CATION CHANNEL ACTIVITY | 26 | 88 | 0.0002857 | 0.002948 |
452 | CAMP CATABOLIC PROCESS | 8 | 14 | 0.0002897 | 0.002982 |
453 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 32 | 117 | 0.0002948 | 0.003028 |
454 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 33 | 122 | 0.0002987 | 0.003061 |
455 | RESPONSE TO AXON INJURY | 17 | 48 | 0.0003093 | 0.003163 |
456 | CYTOKINESIS | 25 | 84 | 0.0003277 | 0.003336 |
457 | REPRODUCTION | 235 | 1297 | 0.0003273 | 0.003336 |
458 | NEUROMUSCULAR JUNCTION DEVELOPMENT | 14 | 36 | 0.0003433 | 0.003465 |
459 | RESPONSE TO ACID CHEMICAL | 70 | 319 | 0.0003431 | 0.003465 |
460 | REGULATION OF MAP KINASE ACTIVITY | 70 | 319 | 0.0003431 | 0.003465 |
461 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 45 | 184 | 0.0003415 | 0.003465 |
462 | REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 26 | 89 | 0.0003477 | 0.003502 |
463 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 35 | 133 | 0.0003528 | 0.003546 |
464 | EPITHELIAL CELL DIFFERENTIATION | 101 | 495 | 0.0003563 | 0.003573 |
465 | INSULIN RECEPTOR SIGNALING PATHWAY | 24 | 80 | 0.0003752 | 0.003754 |
466 | REGULATION OF JNK CASCADE | 40 | 159 | 0.0003853 | 0.003847 |
467 | SEX DIFFERENTIATION | 60 | 266 | 0.0004183 | 0.004168 |
468 | GLUCOSE HOMEOSTASIS | 42 | 170 | 0.0004215 | 0.004173 |
469 | MIDBRAIN DEVELOPMENT | 26 | 90 | 0.0004212 | 0.004173 |
470 | CARBOHYDRATE HOMEOSTASIS | 42 | 170 | 0.0004215 | 0.004173 |
471 | CILIUM MORPHOGENESIS | 49 | 207 | 0.0004323 | 0.004271 |
472 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 9 | 18 | 0.0004479 | 0.004397 |
473 | RETINAL GANGLION CELL AXON GUIDANCE | 9 | 18 | 0.0004479 | 0.004397 |
474 | SMOOTH MUSCLE TISSUE DEVELOPMENT | 9 | 18 | 0.0004479 | 0.004397 |
475 | GLUTAMATE RECEPTOR SIGNALING PATHWAY | 15 | 41 | 0.0004625 | 0.004531 |
476 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 47 | 197 | 0.0004648 | 0.004544 |
477 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 50 | 213 | 0.0004674 | 0.00456 |
478 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 35 | 135 | 0.0004771 | 0.004613 |
479 | CORONARY VASCULATURE DEVELOPMENT | 14 | 37 | 0.0004778 | 0.004613 |
480 | MATING | 14 | 37 | 0.0004778 | 0.004613 |
481 | AXON EXTENSION | 14 | 37 | 0.0004778 | 0.004613 |
482 | CELL GROWTH | 35 | 135 | 0.0004771 | 0.004613 |
483 | NEURON PROJECTION REGENERATION | 13 | 33 | 0.00048 | 0.004618 |
484 | NEGATIVE REGULATION OF NEURON DEATH | 42 | 171 | 0.0004803 | 0.004618 |
485 | REGULATION OF RESPONSE TO WOUNDING | 86 | 413 | 0.0004855 | 0.004658 |
486 | REGULATION OF AMINE TRANSPORT | 22 | 72 | 0.0004887 | 0.004679 |
487 | REGULATION OF SECRETION | 135 | 699 | 0.0004928 | 0.004708 |
488 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 110 | 552 | 0.0005013 | 0.00478 |
489 | RESPONSE TO DRUG | 89 | 431 | 0.0005196 | 0.004944 |
490 | IMMUNE SYSTEM DEVELOPMENT | 115 | 582 | 0.000527 | 0.004994 |
491 | CARDIOCYTE DIFFERENTIATION | 27 | 96 | 0.0005261 | 0.004994 |
492 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 139 | 724 | 0.0005298 | 0.005011 |
493 | NEURAL RETINA DEVELOPMENT | 17 | 50 | 0.0005356 | 0.005055 |
494 | NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 8 | 15 | 0.0005405 | 0.005091 |
495 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 46 | 193 | 0.000543 | 0.005094 |
496 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 75 | 352 | 0.0005424 | 0.005094 |
497 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 45 | 188 | 0.0005624 | 0.005265 |
498 | RETINA LAYER FORMATION | 10 | 22 | 0.000565 | 0.005268 |
499 | SUBPALLIUM DEVELOPMENT | 10 | 22 | 0.000565 | 0.005268 |
500 | CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 16 | 46 | 0.0005812 | 0.005409 |
501 | ASSOCIATIVE LEARNING | 22 | 73 | 0.0006034 | 0.005582 |
502 | RESPONSE TO METHYLMERCURY | 7 | 12 | 0.0006035 | 0.005582 |
503 | VASCULAR SMOOTH MUSCLE CONTRACTION | 7 | 12 | 0.0006035 | 0.005582 |
504 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 46 | 194 | 0.0006118 | 0.005648 |
505 | REGULATION OF CELLULAR RESPONSE TO STRESS | 133 | 691 | 0.0006229 | 0.005739 |
506 | ESTABLISHMENT OF LOCALIZATION BY MOVEMENT ALONG MICROTUBULE | 27 | 97 | 0.000628 | 0.005775 |
507 | REGULATION OF NEUROTRANSMITTER TRANSPORT | 20 | 64 | 0.0006296 | 0.005778 |
508 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 26 | 0.0006369 | 0.005822 |
509 | MICROTUBULE BASED MOVEMENT | 48 | 205 | 0.0006365 | 0.005822 |
510 | REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 78 | 0.0006446 | 0.005881 |
511 | PLATELET DEGRANULATION | 29 | 107 | 0.0006504 | 0.005922 |
512 | POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 14 | 38 | 0.0006547 | 0.005939 |
513 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 14 | 38 | 0.0006547 | 0.005939 |
514 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 50 | 216 | 0.000656 | 0.005939 |
515 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 117 | 0.0006577 | 0.005942 |
516 | MEMBRANE BIOGENESIS | 12 | 30 | 0.0006699 | 0.006018 |
517 | NEGATIVE REGULATION OF CELL MATRIX ADHESION | 12 | 30 | 0.0006699 | 0.006018 |
518 | MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 12 | 30 | 0.0006699 | 0.006018 |
519 | FOREBRAIN NEURON DEVELOPMENT | 13 | 34 | 0.000673 | 0.006034 |
520 | PROTEOGLYCAN METABOLIC PROCESS | 24 | 83 | 0.0006792 | 0.006066 |
521 | REGULATION OF LIPASE ACTIVITY | 24 | 83 | 0.0006792 | 0.006066 |
522 | REGULATION OF ERK1 AND ERK2 CASCADE | 54 | 238 | 0.0006813 | 0.006073 |
523 | TRANSMEMBRANE TRANSPORT | 200 | 1098 | 0.0006852 | 0.006096 |
524 | PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 21 | 69 | 0.0006892 | 0.006119 |
525 | REGULATION OF NEUROTRANSMITTER SECRETION | 17 | 51 | 0.0006943 | 0.006141 |
526 | ARTERY MORPHOGENESIS | 17 | 51 | 0.0006943 | 0.006141 |
527 | ESTABLISHMENT OF LOCALIZATION IN CELL | 293 | 1676 | 0.0007094 | 0.006263 |
528 | STEM CELL PROLIFERATION | 19 | 60 | 0.0007106 | 0.006263 |
529 | PROTEIN DEPHOSPHORYLATION | 45 | 190 | 0.0007147 | 0.006275 |
530 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 45 | 190 | 0.0007147 | 0.006275 |
531 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 26 | 93 | 0.00073 | 0.006397 |
532 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 9 | 19 | 0.0007399 | 0.00646 |
533 | FIBRIL ORGANIZATION | 9 | 19 | 0.0007399 | 0.00646 |
534 | CELL JUNCTION ORGANIZATION | 44 | 185 | 0.0007415 | 0.006461 |
535 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 28 | 103 | 0.0007586 | 0.006598 |
536 | NEGATIVE REGULATION OF KINASE ACTIVITY | 56 | 250 | 0.0007613 | 0.006609 |
537 | REGULATION OF CHEMOTAXIS | 43 | 180 | 0.0007685 | 0.006659 |
538 | NEGATIVE REGULATION OF AXONOGENESIS | 20 | 65 | 0.000785 | 0.006789 |
539 | CRANIAL NERVE DEVELOPMENT | 15 | 43 | 0.0008267 | 0.007123 |
540 | REGULATION OF CATECHOLAMINE SECRETION | 15 | 43 | 0.0008267 | 0.007123 |
541 | PEPTIDYL TYROSINE MODIFICATION | 44 | 186 | 0.000835 | 0.007182 |
542 | ANION TRANSPORT | 101 | 507 | 0.0008407 | 0.007218 |
543 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 10 | 23 | 0.0008682 | 0.007426 |
544 | REGULATION OF METANEPHROS DEVELOPMENT | 10 | 23 | 0.0008682 | 0.007426 |
545 | CELL JUNCTION ASSEMBLY | 33 | 129 | 0.0008758 | 0.007478 |
546 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 14 | 39 | 0.0008841 | 0.007534 |
547 | PROTEIN AUTOPHOSPHORYLATION | 45 | 192 | 0.0009025 | 0.007677 |
548 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 22 | 75 | 0.0009042 | 0.007677 |
549 | NEURON APOPTOTIC PROCESS | 13 | 35 | 0.0009274 | 0.007832 |
550 | POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 13 | 35 | 0.0009274 | 0.007832 |
551 | EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 13 | 35 | 0.0009274 | 0.007832 |
552 | REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 11 | 27 | 0.0009326 | 0.007861 |
553 | NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 8 | 16 | 0.0009416 | 0.007866 |
554 | NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY | 8 | 16 | 0.0009416 | 0.007866 |
555 | RESPONSE TO EPINEPHRINE | 8 | 16 | 0.0009416 | 0.007866 |
556 | STRIATUM DEVELOPMENT | 8 | 16 | 0.0009416 | 0.007866 |
557 | REGULATION OF FATTY ACID BETA OXIDATION | 8 | 16 | 0.0009416 | 0.007866 |
558 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 197 | 1087 | 0.0009666 | 0.00806 |
559 | REGULATION OF MULTICELLULAR ORGANISM GROWTH | 20 | 66 | 0.0009722 | 0.008078 |
560 | REGULATION OF CARDIAC CONDUCTION | 20 | 66 | 0.0009722 | 0.008078 |
561 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 53 | 236 | 0.0009741 | 0.008079 |
562 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 34 | 135 | 0.0009923 | 0.008215 |
563 | AXIS SPECIFICATION | 25 | 90 | 0.001012 | 0.008352 |
564 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 25 | 90 | 0.001012 | 0.008352 |
565 | KIDNEY EPITHELIUM DEVELOPMENT | 32 | 125 | 0.001026 | 0.008449 |
566 | REGULATION OF GLUCOSE TRANSPORT | 27 | 100 | 0.001044 | 0.008571 |
567 | LIMBIC SYSTEM DEVELOPMENT | 27 | 100 | 0.001044 | 0.008571 |
568 | REGULATION OF CALCIUM MEDIATED SIGNALING | 22 | 76 | 0.001098 | 0.008973 |
569 | POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 22 | 76 | 0.001098 | 0.008973 |
570 | RESPONSE TO EXTRACELLULAR STIMULUS | 89 | 441 | 0.001099 | 0.008973 |
571 | LIPID MODIFICATION | 48 | 210 | 0.001108 | 0.009032 |
572 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 17 | 53 | 0.001134 | 0.009211 |
573 | REGULATION OF MICROTUBULE BASED PROCESS | 54 | 243 | 0.001134 | 0.009211 |
574 | EXTRACELLULAR FIBRIL ORGANIZATION | 7 | 13 | 0.001141 | 0.00925 |
575 | ION TRANSMEMBRANE TRANSPORT | 153 | 822 | 0.001146 | 0.009273 |
576 | HINDBRAIN MORPHOGENESIS | 14 | 40 | 0.001177 | 0.009512 |
577 | POSITIVE REGULATION OF GROWTH | 53 | 238 | 0.001192 | 0.00961 |
578 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 48 | 211 | 0.001233 | 0.009928 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 374 | 1737 | 1.276e-15 | 1.185e-12 |
2 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 269 | 1199 | 1.655e-13 | 7.688e-11 |
3 | CYTOSKELETAL PROTEIN BINDING | 192 | 819 | 1.188e-11 | 3.68e-09 |
4 | KINASE BINDING | 149 | 606 | 7.195e-11 | 1.337e-08 |
5 | MACROMOLECULAR COMPLEX BINDING | 293 | 1399 | 6.218e-11 | 1.337e-08 |
6 | PROTEIN COMPLEX BINDING | 208 | 935 | 2.466e-10 | 3.338e-08 |
7 | MOLECULAR FUNCTION REGULATOR | 282 | 1353 | 2.515e-10 | 3.338e-08 |
8 | REGULATORY REGION NUCLEIC ACID BINDING | 183 | 818 | 1.959e-09 | 2.274e-07 |
9 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 147 | 629 | 4.053e-09 | 4.184e-07 |
10 | CELL ADHESION MOLECULE BINDING | 58 | 186 | 9.366e-09 | 8.701e-07 |
11 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 33 | 81 | 1.148e-08 | 9.693e-07 |
12 | KINASE ACTIVITY | 183 | 842 | 1.926e-08 | 1.376e-06 |
13 | GROWTH FACTOR BINDING | 43 | 123 | 1.883e-08 | 1.376e-06 |
14 | PROTEIN KINASE ACTIVITY | 146 | 640 | 2.4e-08 | 1.593e-06 |
15 | PROTEIN HOMODIMERIZATION ACTIVITY | 159 | 722 | 6.872e-08 | 4.256e-06 |
16 | CALCIUM ION BINDING | 154 | 697 | 8.894e-08 | 5.164e-06 |
17 | RECEPTOR BINDING | 289 | 1476 | 9.651e-08 | 5.274e-06 |
18 | TRANSFORMING GROWTH FACTOR BETA BINDING | 12 | 16 | 1.062e-07 | 5.48e-06 |
19 | ENZYME ACTIVATOR ACTIVITY | 111 | 471 | 2.061e-07 | 8.705e-06 |
20 | NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 84 | 329 | 1.83e-07 | 8.705e-06 |
21 | IDENTICAL PROTEIN BINDING | 242 | 1209 | 1.89e-07 | 8.705e-06 |
22 | RIBONUCLEOTIDE BINDING | 351 | 1860 | 2.006e-07 | 8.705e-06 |
23 | ACTIN BINDING | 96 | 393 | 2.395e-07 | 9.674e-06 |
24 | PROTEIN DIMERIZATION ACTIVITY | 230 | 1149 | 3.852e-07 | 1.491e-05 |
25 | GLYCOSAMINOGLYCAN BINDING | 58 | 205 | 4.031e-07 | 1.498e-05 |
26 | DOUBLE STRANDED DNA BINDING | 162 | 764 | 6.521e-07 | 2.33e-05 |
27 | SULFUR COMPOUND BINDING | 63 | 234 | 8.802e-07 | 3.028e-05 |
28 | MICROTUBULE BINDING | 56 | 201 | 1.086e-06 | 3.564e-05 |
29 | PROTEIN DOMAIN SPECIFIC BINDING | 136 | 624 | 1.112e-06 | 3.564e-05 |
30 | TUBULIN BINDING | 70 | 273 | 1.583e-06 | 4.743e-05 |
31 | ENZYME REGULATOR ACTIVITY | 194 | 959 | 1.576e-06 | 4.743e-05 |
32 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 198 | 992 | 3.112e-06 | 9.033e-05 |
33 | INTEGRIN BINDING | 34 | 105 | 4.068e-06 | 0.0001145 |
34 | HEPARIN BINDING | 45 | 157 | 5.289e-06 | 0.0001436 |
35 | ADENYL NUCLEOTIDE BINDING | 284 | 1514 | 5.41e-06 | 0.0001436 |
36 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 24 | 64 | 6.307e-06 | 0.0001628 |
37 | ZINC ION BINDING | 223 | 1155 | 8.363e-06 | 0.00021 |
38 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 73 | 303 | 1.065e-05 | 0.0002604 |
39 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 39 | 133 | 1.219e-05 | 0.0002904 |
40 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 99 | 445 | 1.293e-05 | 0.0003004 |
41 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 58 | 228 | 1.541e-05 | 0.0003492 |
42 | SMAD BINDING | 25 | 72 | 1.948e-05 | 0.0004308 |
43 | TRANSITION METAL ION BINDING | 261 | 1400 | 2.101e-05 | 0.0004538 |
44 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 101 | 464 | 2.736e-05 | 0.0005672 |
45 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 123 | 588 | 2.748e-05 | 0.0005672 |
46 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 20 | 53 | 3.3e-05 | 0.0006522 |
47 | TRANSLATION REPRESSOR ACTIVITY | 11 | 20 | 3.26e-05 | 0.0006522 |
48 | GATED CHANNEL ACTIVITY | 75 | 325 | 3.931e-05 | 0.0007608 |
49 | SH3 DOMAIN BINDING | 34 | 116 | 4.33e-05 | 0.000821 |
50 | PROTEIN TYROSINE KINASE BINDING | 20 | 54 | 4.518e-05 | 0.0008395 |
51 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 75 | 328 | 5.425e-05 | 0.0009691 |
52 | SEQUENCE SPECIFIC DNA BINDING | 198 | 1037 | 5.325e-05 | 0.0009691 |
53 | X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 9 | 15 | 7.025e-05 | 0.001216 |
54 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 27 | 86 | 7.069e-05 | 0.001216 |
55 | BINDING BRIDGING | 45 | 173 | 7.484e-05 | 0.001264 |
56 | CYCLIC NUCLEOTIDE BINDING | 15 | 36 | 8.406e-05 | 0.00137 |
57 | RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY | 15 | 36 | 8.406e-05 | 0.00137 |
58 | PHOSPHATIDYLINOSITOL BINDING | 50 | 200 | 9.246e-05 | 0.001481 |
59 | TRANSCRIPTION FACTOR BINDING | 109 | 524 | 9.721e-05 | 0.001531 |
60 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 23 | 70 | 0.0001098 | 0.0017 |
61 | PHOSPHOLIPASE BINDING | 10 | 19 | 0.0001234 | 0.001879 |
62 | CATION CHANNEL ACTIVITY | 68 | 298 | 0.0001258 | 0.001885 |
63 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 44 | 172 | 0.0001353 | 0.001995 |
64 | POTASSIUM CHANNEL REGULATOR ACTIVITY | 17 | 46 | 0.0001709 | 0.002481 |
65 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 80 | 368 | 0.0001864 | 0.002664 |
66 | CHEMOREPELLENT ACTIVITY | 12 | 27 | 0.0002069 | 0.002913 |
67 | EXTRACELLULAR GLUTAMATE GATED ION CHANNEL ACTIVITY | 10 | 20 | 0.0002142 | 0.00297 |
68 | CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 29 | 101 | 0.0002268 | 0.003099 |
69 | CYTOKINE BINDING | 27 | 92 | 0.0002487 | 0.003209 |
70 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 16 | 43 | 0.0002408 | 0.003209 |
71 | ION CHANNEL BINDING | 31 | 111 | 0.000243 | 0.003209 |
72 | PHOSPHOLIPID BINDING | 78 | 360 | 0.0002484 | 0.003209 |
73 | CHANNEL REGULATOR ACTIVITY | 35 | 131 | 0.0002581 | 0.003241 |
74 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 17 | 0.0002576 | 0.003241 |
75 | PHOSPHOLIPID TRANSPORTER ACTIVITY | 17 | 48 | 0.0003093 | 0.003831 |
76 | HISTONE ACETYLTRANSFERASE BINDING | 12 | 28 | 0.0003137 | 0.003835 |
77 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 60 | 264 | 0.0003399 | 0.004101 |
78 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 69 | 315 | 0.0003969 | 0.004727 |
79 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 11 | 25 | 0.0004236 | 0.004981 |
80 | PROTEIN TYROSINE KINASE ACTIVITY | 43 | 176 | 0.0004671 | 0.005424 |
81 | GUANYL NUCLEOTIDE BINDING | 82 | 390 | 0.0004755 | 0.005454 |
82 | GTPASE BINDING | 65 | 295 | 0.0004869 | 0.005516 |
83 | RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY | 26 | 91 | 0.0005081 | 0.005687 |
84 | PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 31 | 116 | 0.0005615 | 0.00621 |
85 | THIOL DEPENDENT UBIQUITIN SPECIFIC PROTEASE ACTIVITY | 22 | 73 | 0.0006034 | 0.006595 |
86 | PROTEIN KINASE A BINDING | 15 | 42 | 0.0006223 | 0.006722 |
87 | CALMODULIN BINDING | 43 | 179 | 0.0006803 | 0.007264 |
88 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 17 | 51 | 0.0006943 | 0.007329 |
89 | PROLINE RICH REGION BINDING | 9 | 19 | 0.0007399 | 0.007638 |
90 | X1 PHOSPHATIDYLINOSITOL BINDING | 9 | 19 | 0.0007399 | 0.007638 |
91 | R SMAD BINDING | 10 | 23 | 0.0008682 | 0.008767 |
92 | CAMP BINDING | 10 | 23 | 0.0008682 | 0.008767 |
93 | TRANSCRIPTION COACTIVATOR ACTIVITY | 64 | 296 | 0.0008981 | 0.008971 |
94 | PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY | 8 | 16 | 0.0009416 | 0.009112 |
95 | CGMP BINDING | 8 | 16 | 0.0009416 | 0.009112 |
96 | TRANSLATION REGULATOR ACTIVITY | 13 | 35 | 0.0009274 | 0.009112 |
97 | LIPID BINDING | 126 | 657 | 0.0009834 | 0.009419 |
98 | PDZ DOMAIN BINDING | 25 | 90 | 0.001012 | 0.009597 |
99 | TRANSMEMBRANE TRANSPORTER ACTIVITY | 182 | 997 | 0.00106 | 0.009949 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PART | 333 | 1265 | 1.006e-28 | 5.876e-26 |
2 | NEURON PROJECTION | 262 | 942 | 2.014e-26 | 5.88e-24 |
3 | CELL PROJECTION | 423 | 1786 | 6.385e-26 | 1.243e-23 |
4 | SYNAPSE | 214 | 754 | 7.076e-23 | 1.033e-20 |
5 | MEMBRANE REGION | 279 | 1134 | 1.737e-19 | 2.029e-17 |
6 | POSTSYNAPSE | 123 | 378 | 1.254e-18 | 1.221e-16 |
7 | SOMATODENDRITIC COMPARTMENT | 180 | 650 | 3.525e-18 | 2.941e-16 |
8 | PLASMA MEMBRANE REGION | 230 | 929 | 1.599e-16 | 1.167e-14 |
9 | DENDRITE | 134 | 451 | 1.822e-16 | 1.182e-14 |
10 | CELL JUNCTION | 271 | 1151 | 2.724e-16 | 1.591e-14 |
11 | SYNAPSE PART | 166 | 610 | 4.399e-16 | 2.335e-14 |
12 | PROTEINACEOUS EXTRACELLULAR MATRIX | 107 | 356 | 8.969e-14 | 4.365e-12 |
13 | AXON | 119 | 418 | 2.495e-13 | 1.121e-11 |
14 | EXTRACELLULAR MATRIX COMPONENT | 52 | 125 | 2.897e-13 | 1.208e-11 |
15 | EXTRACELLULAR MATRIX | 120 | 426 | 4.41e-13 | 1.717e-11 |
16 | CELL PROJECTION PART | 220 | 946 | 8.071e-13 | 2.946e-11 |
17 | EXCITATORY SYNAPSE | 67 | 197 | 9.578e-12 | 3.29e-10 |
18 | CELL BODY | 128 | 494 | 4.21e-11 | 1.366e-09 |
19 | SYNAPTIC MEMBRANE | 79 | 261 | 1.063e-10 | 3.268e-09 |
20 | BASEMENT MEMBRANE | 38 | 93 | 8.263e-10 | 2.413e-08 |
21 | POSTSYNAPTIC MEMBRANE | 64 | 205 | 1.554e-09 | 4.321e-08 |
22 | CYTOSKELETON | 377 | 1967 | 1.096e-08 | 2.783e-07 |
23 | CELL LEADING EDGE | 92 | 350 | 1.078e-08 | 2.783e-07 |
24 | PLASMA MEMBRANE RAFT | 34 | 86 | 1.716e-08 | 4.176e-07 |
25 | SITE OF POLARIZED GROWTH | 49 | 149 | 1.95e-08 | 4.555e-07 |
26 | MEMBRANE MICRODOMAIN | 78 | 288 | 3.535e-08 | 7.94e-07 |
27 | PLASMA MEMBRANE PROTEIN COMPLEX | 121 | 510 | 3.963e-08 | 8.572e-07 |
28 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 319 | 1649 | 6.766e-08 | 1.411e-06 |
29 | COATED PIT | 28 | 67 | 7.585e-08 | 1.48e-06 |
30 | ANCHORING JUNCTION | 116 | 489 | 7.603e-08 | 1.48e-06 |
31 | CELL SUBSTRATE JUNCTION | 98 | 398 | 1.201e-07 | 2.262e-06 |
32 | AXON PART | 61 | 219 | 3.709e-07 | 6.769e-06 |
33 | PERINUCLEAR REGION OF CYTOPLASM | 138 | 642 | 2.05e-06 | 3.628e-05 |
34 | GOLGI APPARATUS | 275 | 1445 | 2.388e-06 | 4.102e-05 |
35 | NEURON SPINE | 38 | 121 | 2.622e-06 | 4.375e-05 |
36 | ACTIN CYTOSKELETON | 101 | 444 | 3.881e-06 | 6.296e-05 |
37 | LAMELLIPODIUM | 48 | 172 | 5.873e-06 | 9.27e-05 |
38 | RECEPTOR COMPLEX | 78 | 327 | 7.985e-06 | 0.0001227 |
39 | NEURONAL POSTSYNAPTIC DENSITY | 21 | 53 | 8.705e-06 | 0.0001304 |
40 | CELL SURFACE | 155 | 757 | 9.002e-06 | 0.0001314 |
41 | MICROTUBULE CYTOSKELETON | 208 | 1068 | 9.542e-06 | 0.0001359 |
42 | PRIMARY CILIUM | 54 | 205 | 1.028e-05 | 0.0001429 |
43 | SARCOLEMMA | 37 | 125 | 1.599e-05 | 0.0002172 |
44 | CELL CELL CONTACT ZONE | 23 | 64 | 2.198e-05 | 0.000279 |
45 | CYTOPLASMIC SIDE OF MEMBRANE | 46 | 170 | 2.166e-05 | 0.000279 |
46 | EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 39 | 136 | 2.151e-05 | 0.000279 |
47 | EXTRINSIC COMPONENT OF MEMBRANE | 62 | 252 | 2.427e-05 | 0.0003015 |
48 | INTRACELLULAR VESICLE | 237 | 1259 | 2.645e-05 | 0.0003218 |
49 | INTERSTITIAL MATRIX | 9 | 14 | 3.235e-05 | 0.0003856 |
50 | EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 30 | 98 | 4.9e-05 | 0.0005723 |
51 | FILOPODIUM | 29 | 94 | 5.551e-05 | 0.0006356 |
52 | INTERCALATED DISC | 19 | 51 | 6.341e-05 | 0.0007121 |
53 | MICROTUBULE END | 11 | 22 | 0.0001028 | 0.001133 |
54 | I BAND | 34 | 121 | 0.0001096 | 0.001185 |
55 | PLATELET ALPHA GRANULE | 24 | 75 | 0.0001254 | 0.001332 |
56 | PRESYNAPSE | 65 | 283 | 0.0001437 | 0.001498 |
57 | SIDE OF MEMBRANE | 91 | 428 | 0.000161 | 0.001649 |
58 | CYTOSKELETAL PART | 260 | 1436 | 0.0001656 | 0.001668 |
59 | COMPLEX OF COLLAGEN TRIMERS | 11 | 23 | 0.0001709 | 0.001691 |
60 | NEURON PROJECTION TERMINUS | 35 | 129 | 0.0001869 | 0.001819 |
61 | CENTROSOME | 101 | 487 | 0.0001931 | 0.001849 |
62 | MICROTUBULE ORGANIZING CENTER | 124 | 623 | 0.0002403 | 0.002263 |
63 | TRANSPORTER COMPLEX | 71 | 321 | 0.0002448 | 0.00227 |
64 | MICROTUBULE | 86 | 405 | 0.0002508 | 0.002288 |
65 | MICROTUBULE PLUS END | 9 | 17 | 0.0002576 | 0.002315 |
66 | CATION CHANNEL COMPLEX | 42 | 167 | 0.0002815 | 0.002491 |
67 | NONMOTILE PRIMARY CILIUM | 36 | 137 | 0.000302 | 0.002632 |
68 | CYTOPLASMIC REGION | 63 | 287 | 0.0006526 | 0.005605 |
69 | CONTRACTILE FIBER | 49 | 211 | 0.0006842 | 0.005791 |
70 | OUTER MEMBRANE | 45 | 190 | 0.0007147 | 0.005963 |
71 | MEMBRANE PROTEIN COMPLEX | 187 | 1020 | 0.0007375 | 0.006066 |
72 | ACTIN BASED CELL PROJECTION | 43 | 181 | 0.0008666 | 0.007029 |
73 | APICAL PLASMA MEMBRANE | 63 | 292 | 0.001037 | 0.008297 |
74 | CELL PROJECTION MEMBRANE | 64 | 298 | 0.001075 | 0.008485 |
75 | ENDOPLASMIC RETICULUM | 284 | 1631 | 0.001093 | 0.008512 |
76 | APICAL PART OF CELL | 75 | 361 | 0.001146 | 0.00865 |
77 | CLATHRIN COATED VESICLE | 38 | 157 | 0.001163 | 0.00865 |
78 | AXONAL GROWTH CONE | 9 | 20 | 0.00117 | 0.00865 |
79 | FILAMENTOUS ACTIN | 9 | 20 | 0.00117 | 0.00865 |
80 | VACUOLE | 211 | 1180 | 0.001299 | 0.009485 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04510_Focal_adhesion | 62 | 200 | 3.781e-09 | 6.806e-07 | |
2 | hsa04014_Ras_signaling_pathway | 65 | 236 | 2.445e-07 | 1.655e-05 | |
3 | hsa04270_Vascular_smooth_muscle_contraction | 39 | 116 | 2.758e-07 | 1.655e-05 | |
4 | hsa04020_Calcium_signaling_pathway | 50 | 177 | 2.592e-06 | 0.0001167 | |
5 | hsa04310_Wnt_signaling_pathway | 44 | 151 | 4.18e-06 | 0.0001505 | |
6 | hsa04540_Gap_junction | 30 | 90 | 7.676e-06 | 0.0002303 | |
7 | hsa04360_Axon_guidance | 38 | 130 | 1.696e-05 | 0.0004362 | |
8 | hsa04010_MAPK_signaling_pathway | 65 | 268 | 2.53e-05 | 0.0005693 | |
9 | hsa04720_Long.term_potentiation | 24 | 70 | 3.599e-05 | 0.0007199 | |
10 | hsa04512_ECM.receptor_interaction | 27 | 85 | 5.633e-05 | 0.001014 | |
11 | hsa04810_Regulation_of_actin_cytoskeleton | 53 | 214 | 7.563e-05 | 0.001165 | |
12 | hsa04520_Adherens_junction | 24 | 73 | 7.765e-05 | 0.001165 | |
13 | hsa04070_Phosphatidylinositol_signaling_system | 25 | 78 | 8.886e-05 | 0.00123 | |
14 | hsa04971_Gastric_acid_secretion | 24 | 74 | 9.901e-05 | 0.001273 | |
15 | hsa04730_Long.term_depression | 23 | 70 | 0.0001098 | 0.001317 | |
16 | hsa04151_PI3K_AKT_signaling_pathway | 77 | 351 | 0.0001807 | 0.002033 | |
17 | hsa04916_Melanogenesis | 29 | 101 | 0.0002268 | 0.002401 | |
18 | hsa04350_TGF.beta_signaling_pathway | 25 | 85 | 4e-04 | 0.004 | |
19 | hsa04722_Neurotrophin_signaling_pathway | 33 | 127 | 0.000653 | 0.006186 | |
20 | hsa04910_Insulin_signaling_pathway | 35 | 138 | 0.0007365 | 0.006628 | |
21 | hsa04390_Hippo_signaling_pathway | 38 | 154 | 0.0007908 | 0.006778 | |
22 | hsa04912_GnRH_signaling_pathway | 26 | 101 | 0.002666 | 0.02182 | |
23 | hsa02010_ABC_transporters | 14 | 44 | 0.003282 | 0.02569 | |
24 | hsa04920_Adipocytokine_signaling_pathway | 19 | 68 | 0.003612 | 0.02702 | |
25 | hsa04710_Circadian_rhythm_._mammal | 9 | 23 | 0.003752 | 0.02702 | |
26 | hsa04970_Salivary_secretion | 23 | 89 | 0.004321 | 0.02992 | |
27 | hsa00350_Tyrosine_metabolism | 13 | 41 | 0.004693 | 0.03129 | |
28 | hsa04972_Pancreatic_secretion | 25 | 101 | 0.00552 | 0.03549 | |
29 | hsa04012_ErbB_signaling_pathway | 22 | 87 | 0.006817 | 0.04231 | |
30 | hsa04514_Cell_adhesion_molecules_.CAMs. | 31 | 136 | 0.007991 | 0.04795 | |
31 | hsa04144_Endocytosis | 42 | 203 | 0.01339 | 0.07778 | |
32 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 12 | 42 | 0.01564 | 0.08773 | |
33 | hsa00562_Inositol_phosphate_metabolism | 15 | 57 | 0.01608 | 0.08773 | |
34 | hsa04962_Vasopressin.regulated_water_reabsorption | 12 | 44 | 0.02255 | 0.1194 | |
35 | hsa04914_Progesterone.mediated_oocyte_maturation | 20 | 87 | 0.02662 | 0.1369 | |
36 | hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate | 8 | 26 | 0.02927 | 0.1463 | |
37 | hsa04530_Tight_junction | 28 | 133 | 0.03089 | 0.1503 | |
38 | hsa04210_Apoptosis | 20 | 89 | 0.03331 | 0.1559 | |
39 | hsa04670_Leukocyte_transendothelial_migration | 25 | 117 | 0.03379 | 0.1559 | |
40 | hsa04115_p53_signaling_pathway | 16 | 69 | 0.04106 | 0.1848 | |
41 | hsa04114_Oocyte_meiosis | 24 | 114 | 0.04316 | 0.1895 | |
42 | hsa00300_Lysine_biosynthesis | 2 | 3 | 0.05888 | 0.2523 | |
43 | hsa04320_Dorso.ventral_axis_formation | 7 | 25 | 0.06449 | 0.2699 | |
44 | hsa00120_Primary_bile_acid_biosynthesis | 5 | 16 | 0.07451 | 0.2985 | |
45 | hsa00230_Purine_metabolism | 31 | 162 | 0.07462 | 0.2985 | |
46 | hsa00360_Phenylalanine_metabolism | 5 | 17 | 0.09325 | 0.3516 | |
47 | hsa04614_Renin.angiotensin_system | 5 | 17 | 0.09325 | 0.3516 | |
48 | hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate | 6 | 22 | 0.09376 | 0.3516 | |
49 | hsa04664_Fc_epsilon_RI_signaling_pathway | 16 | 79 | 0.1135 | 0.4109 | |
50 | hsa00670_One_carbon_pool_by_folate | 5 | 18 | 0.1141 | 0.4109 | |
51 | hsa00760_Nicotinate_and_nicotinamide_metabolism | 6 | 24 | 0.1314 | 0.4637 | |
52 | hsa00071_Fatty_acid_metabolism | 9 | 43 | 0.1743 | 0.6033 | |
53 | hsa00982_Drug_metabolism_._cytochrome_P450 | 14 | 73 | 0.1812 | 0.6155 | |
54 | hsa00280_Valine._leucine_and_isoleucine_degradation | 9 | 44 | 0.1923 | 0.6409 | |
55 | hsa04974_Protein_digestion_and_absorption | 15 | 81 | 0.2079 | 0.675 | |
56 | hsa04145_Phagosome | 27 | 156 | 0.2121 | 0.675 | |
57 | hsa00740_Riboflavin_metabolism | 3 | 11 | 0.2137 | 0.675 | |
58 | hsa04640_Hematopoietic_cell_lineage | 16 | 88 | 0.2197 | 0.682 | |
59 | hsa03320_PPAR_signaling_pathway | 13 | 70 | 0.2261 | 0.6899 | |
60 | hsa00340_Histidine_metabolism | 6 | 29 | 0.2494 | 0.7483 | |
61 | hsa04630_Jak.STAT_signaling_pathway | 26 | 155 | 0.2694 | 0.7886 | |
62 | hsa04130_SNARE_interactions_in_vesicular_transport | 7 | 36 | 0.2754 | 0.7886 | |
63 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 6 | 30 | 0.276 | 0.7886 | |
64 | hsa00564_Glycerophospholipid_metabolism | 14 | 80 | 0.2871 | 0.8076 | |
65 | hsa04662_B_cell_receptor_signaling_pathway | 13 | 75 | 0.3096 | 0.8572 | |
66 | hsa00310_Lysine_degradation | 8 | 44 | 0.3195 | 0.8713 | |
67 | hsa03450_Non.homologous_end.joining | 3 | 14 | 0.342 | 0.9188 | |
68 | hsa04150_mTOR_signaling_pathway | 9 | 52 | 0.3577 | 0.9441 | |
69 | hsa04062_Chemokine_signaling_pathway | 30 | 189 | 0.3619 | 0.9441 | |
70 | hsa01040_Biosynthesis_of_unsaturated_fatty_acids | 4 | 21 | 0.3762 | 0.9539 | |
71 | hsa00600_Sphingolipid_metabolism | 7 | 40 | 0.3763 | 0.9539 | |
72 | hsa00072_Synthesis_and_degradation_of_ketone_bodies | 2 | 9 | 0.392 | 0.9801 | |
73 | hsa00410_beta.Alanine_metabolism | 4 | 22 | 0.4118 | 1 | |
74 | hsa00770_Pantothenate_and_CoA_biosynthesis | 3 | 16 | 0.4274 | 1 | |
75 | hsa04744_Phototransduction | 5 | 29 | 0.4296 | 1 | |
76 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 15 | 95 | 0.4313 | 1 | |
77 | hsa00270_Cysteine_and_methionine_metabolism | 6 | 36 | 0.4428 | 1 | |
78 | hsa00565_Ether_lipid_metabolism | 6 | 36 | 0.4428 | 1 | |
79 | hsa00430_Taurine_and_hypotaurine_metabolism | 2 | 10 | 0.4467 | 1 | |
80 | hsa00591_Linoleic_acid_metabolism | 5 | 30 | 0.4603 | 1 | |
81 | hsa00650_Butanoate_metabolism | 5 | 30 | 0.4603 | 1 | |
82 | hsa03022_Basal_transcription_factors | 6 | 37 | 0.4704 | 1 | |
83 | hsa04973_Carbohydrate_digestion_and_absorption | 7 | 44 | 0.4784 | 1 | |
84 | hsa04976_Bile_secretion | 11 | 71 | 0.481 | 1 | |
85 | hsa03420_Nucleotide_excision_repair | 7 | 45 | 0.5034 | 1 | |
86 | hsa00250_Alanine._aspartate_and_glutamate_metabolism | 5 | 32 | 0.5201 | 1 | |
87 | hsa00260_Glycine._serine_and_threonine_metabolism | 5 | 32 | 0.5201 | 1 | |
88 | hsa00640_Propanoate_metabolism | 5 | 32 | 0.5201 | 1 | |
89 | hsa04380_Osteoclast_differentiation | 19 | 128 | 0.5269 | 1 | |
90 | hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series | 4 | 26 | 0.5476 | 1 | |
91 | hsa04610_Complement_and_coagulation_cascades | 10 | 69 | 0.5765 | 1 | |
92 | hsa04370_VEGF_signaling_pathway | 11 | 76 | 0.5771 | 1 | |
93 | hsa03015_mRNA_surveillance_pathway | 12 | 83 | 0.5779 | 1 | |
94 | hsa00592_alpha.Linolenic_acid_metabolism | 3 | 20 | 0.5832 | 1 | |
95 | hsa00380_Tryptophan_metabolism | 6 | 42 | 0.6006 | 1 | |
96 | hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 | 10 | 71 | 0.6145 | 1 | |
97 | hsa00480_Glutathione_metabolism | 7 | 50 | 0.6207 | 1 | |
98 | hsa00561_Glycerolipid_metabolism | 7 | 50 | 0.6207 | 1 | |
99 | hsa00051_Fructose_and_mannose_metabolism | 5 | 36 | 0.6299 | 1 | |
100 | hsa04660_T_cell_receptor_signaling_pathway | 15 | 108 | 0.6417 | 1 | |
101 | hsa00590_Arachidonic_acid_metabolism | 8 | 59 | 0.658 | 1 | |
102 | hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series | 2 | 15 | 0.6721 | 1 | |
103 | hsa00910_Nitrogen_metabolism | 3 | 23 | 0.6807 | 1 | |
104 | hsa03060_Protein_export | 3 | 23 | 0.6807 | 1 | |
105 | hsa04975_Fat_digestion_and_absorption | 6 | 46 | 0.691 | 1 | |
106 | hsa04260_Cardiac_muscle_contraction | 10 | 77 | 0.7171 | 1 | |
107 | hsa04110_Cell_cycle | 17 | 128 | 0.7182 | 1 | |
108 | hsa04340_Hedgehog_signaling_pathway | 7 | 56 | 0.7387 | 1 | |
109 | hsa04146_Peroxisome | 10 | 79 | 0.747 | 1 | |
110 | hsa04672_Intestinal_immune_network_for_IgA_production | 6 | 49 | 0.7492 | 1 | |
111 | hsa04120_Ubiquitin_mediated_proteolysis | 18 | 139 | 0.7607 | 1 | |
112 | hsa00531_Glycosaminoglycan_degradation | 2 | 19 | 0.7936 | 1 | |
113 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 17 | 136 | 0.8047 | 1 | |
114 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 21 | 168 | 0.8249 | 1 | |
115 | hsa00500_Starch_and_sucrose_metabolism | 6 | 54 | 0.8278 | 1 | |
116 | hsa04612_Antigen_processing_and_presentation | 9 | 78 | 0.8318 | 1 | |
117 | hsa04330_Notch_signaling_pathway | 5 | 47 | 0.8428 | 1 | |
118 | hsa00620_Pyruvate_metabolism | 4 | 40 | 0.8611 | 1 | |
119 | hsa00010_Glycolysis_._Gluconeogenesis | 7 | 65 | 0.8629 | 1 | |
120 | hsa04142_Lysosome | 14 | 121 | 0.8706 | 1 | |
121 | hsa03430_Mismatch_repair | 2 | 23 | 0.8735 | 1 | |
122 | hsa04964_Proximal_tubule_bicarbonate_reclamation | 2 | 23 | 0.8735 | 1 | |
123 | hsa04977_Vitamin_digestion_and_absorption | 2 | 24 | 0.8884 | 1 | |
124 | hsa00860_Porphyrin_and_chlorophyll_metabolism | 4 | 43 | 0.8964 | 1 | |
125 | hsa04742_Taste_transduction | 5 | 52 | 0.8992 | 1 | |
126 | hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis | 2 | 25 | 0.9017 | 1 | |
127 | hsa04622_RIG.I.like_receptor_signaling_pathway | 7 | 71 | 0.9151 | 1 | |
128 | hsa04966_Collecting_duct_acid_secretion | 2 | 27 | 0.9239 | 1 | |
129 | hsa00240_Pyrimidine_metabolism | 10 | 99 | 0.9328 | 1 | |
130 | hsa03440_Homologous_recombination | 2 | 28 | 0.9332 | 1 | |
131 | hsa00140_Steroid_hormone_biosynthesis | 5 | 57 | 0.9371 | 1 | |
132 | hsa00510_N.Glycan_biosynthesis | 4 | 49 | 0.944 | 1 | |
133 | hsa04620_Toll.like_receptor_signaling_pathway | 10 | 102 | 0.9465 | 1 | |
134 | hsa04621_NOD.like_receptor_signaling_pathway | 5 | 59 | 0.9483 | 1 | |
135 | hsa00330_Arginine_and_proline_metabolism | 4 | 54 | 0.9674 | 1 | |
136 | hsa00830_Retinol_metabolism | 5 | 64 | 0.9688 | 1 | |
137 | hsa03410_Base_excision_repair | 2 | 34 | 0.9699 | 1 | |
138 | hsa04140_Regulation_of_autophagy | 2 | 34 | 0.9699 | 1 | |
139 | hsa00514_Other_types_of_O.glycan_biosynthesis | 3 | 46 | 0.9743 | 1 | |
140 | hsa03030_DNA_replication | 2 | 36 | 0.977 | 1 | |
141 | hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism | 3 | 48 | 0.9798 | 1 | |
142 | hsa03018_RNA_degradation | 5 | 71 | 0.9851 | 1 | |
143 | hsa04623_Cytosolic_DNA.sensing_pathway | 3 | 56 | 0.9926 | 1 | |
144 | hsa03008_Ribosome_biogenesis_in_eukaryotes | 5 | 81 | 0.9951 | 1 | |
145 | hsa00983_Drug_metabolism_._other_enzymes | 2 | 52 | 0.9975 | 1 | |
146 | hsa03013_RNA_transport | 11 | 152 | 0.9985 | 1 | |
147 | hsa03010_Ribosome | 5 | 92 | 0.9986 | 1 | |
148 | hsa00970_Aminoacyl.tRNA_biosynthesis | 2 | 63 | 0.9995 | 1 | |
149 | hsa03040_Spliceosome | 6 | 128 | 0.9999 | 1 | |
150 | hsa00190_Oxidative_phosphorylation | 4 | 132 | 1 | 1 | |
151 | hsa04740_Olfactory_transduction | 12 | 388 | 1 | 1 |